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The work presented in this thesis focus mainly on two areas (i) designing specific 
probes to target a particular class of proteases using activity based affinity tag  approach 
(ii) collection of substrate specificity/binding data of proteases using positional scanning 
peptide libraries.  
Chapter 2 of the thesis present our efforts towards the design and synthesis of 
small molecule probes to target caspases, enzymes which play a key mediating role in 
apoptosis or programmed cell death. At first, we synthesized a fluoromethyl ketone 
containing activity-based probe that specifically target caspases in an in vitro proteomic 
experiment. Later on, we extended this approach to the in vivo labeling of caspases in 
apoptotic HeLa cells by the use of modified probes which are cell permeable. The 
attractive feature of our strategy is that it allows for the large scale identification of novel 
enzyme-associating proteins.  
Chapter 3, 4 and 5 mainly focus on the synthesis of positional scanning 
combinatorial libraries of peptide substrates/inhibitors to profile proteases. These works 
concentrate on the studies of the substrate specificity or “fingerprinting” of various 
classes of proteases. For example, a positional scanning library of 7-amino-4 
carbamoylmethylcoumarin (ACC) conjugated peptides were synthesized and assayed 
against different classes of proteases. The substrate specificity profiles of various classes 
of proteases were successfully obtained using this library. Other efforts include the 
activity-based profiling of cysteine proteases using a twenty member library of vinyl 
sulfone-containing peptides with varying P1 position and the synthesis of a positional 
 vii
scanning combinatorial library of peptidyl hydroxamates to investigate the substrate 
specificity of metalloproteases at the P2-P4 positions.  
A brief attempt for bioimaging using small molecular probes also has been done 
as illustrated in chapter 6. 
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Chapter 1 Introduction 
1.1 Proteomics  
Proteomics studies proteins, their structures, localizations, post-translational 
modifications, functions and interactions with other proteins. The mapping of protein 
structure-function holds the key for better understanding of cellular functions under both 
normal and diseased states, which is critical for modern drug discovery. The completion 
of the Human Genome Project has no doubt been a major achievement in scientific 
research, opening up new and exciting possibilities to fully map and characterize all 
proteins expressed in cells [1]. However, the study of human proteome presents scientists 
with a task much more daunting than the human genome project. Functional assignment 
to these immense numbers of novel genes and gene products has become essential. In 
fact, the estimated > 100,000 different proteins expressed from 30000-40000 human 
genes make it extremely challenging, if not impossible with existing protein analysis 
techniques, to map the entire cellular functions at the translational level. Consequently, 
there have been rapid advances in the techniques and methods capable of large-scale 
proteomic studies. Among them, the recently developed high-throughput screening 
methods have enabled scientists to analyze proteins quickly and efficiently at an 
organism-wide scale. Since last couple of years our group has been focusing on the 
development or fine-tuning of the various methods for protein profiling, [2-29] a handful 
of which will be described in the coming sections of this thesis.   
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1.2 Conventional techniques for protein profiling 
The conventional two-dimensional gel electrophoresis (2D-GE), in combination 
with advanced mass spectrometric techniques, has facilitated the rapid characterization of 
thousands of proteins in a single polyacrylamide gel. The technique has the ability to 
separate thousands of proteins in a specific cell or tissue, including their posttranslational 
modified forms. Thus the method is well suitable for the global analysis of protein 
expression in an organism. This, together with the newly developed activity-based 
profiling approaches that target different classes of proteins, has now allowed the study of 
protein functions based on their intrinsic enzymatic activities [5, 9]. However, 2D-GE 
suffers from a number of long-standing problems, including low throughput, a limited 
dynamic detection range, poor reproducibility, low sensitivity, as well as its difficulties in 
analyzing hydrophobic, small, and very basic or acidic proteins. Incremental 
improvements in the 2D-GE technology, including the use of sensitive staining methods 
and higher-resolving gels, and sample fractionation prior to 2D-GE, have alleviated some 
of these problems [30, 31]. Differential gel electrophoresis (DIGE) [32] and multiplexed 
proteomics approach (MP approach) [33] are some other recent developments related to 
2D-GE. Yates and co-workers introduced a multidimensional protein identification 
technology (MudPIT) [34]. In this technique, multiple types of columns are coupled 
together to separate proteins using different physiochemical properties in addition to 
molecular weights and charges, thereby extending the analytical range to proteins having 
high or low molecular weights, as well as low-abundance and insoluble proteins. MudPIT 
also allows the flexibility of incorporating a suitable affinity column to enable selective 
analysis of protein complexes and protein-protein interactions.  
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An elegant chemical method for quantitative proteomics has been developed by 
Gygi et al in 1999. Among different isotope-based proteomics techniques, the isotope-
coded affinity tagging (ICAT™) approach utilizes stable-isotope labeling to perform 
quantitative analysis of paired protein samples, followed by separation and identification 
of proteins within the complex mixtures with liquid chromatography and mass 
spectrometry [35]. The method relies on the use of an affinity based approach which 
permits the quantitative comparison of protein abundances between complex proteomes 
by MS analysis. Instead of resorting to conventional protein-staining methods for 
quantification, the authors have used a chemical probe composed of a reactive group 
capable of covalently binding to a defined subset of amino acid side chains, an 
isotopically coded linker and an affinity tag for the isolation of reactive peptides. More 
recently, the gel-based ICAT has also been reported [36].  The ICAT approach is able to 
simplify the analysis of the proteome mixture by two orders of magnitude based on the 
occurrence of cysteine in proteins (1.7 %).  However, the strategy is limited to probing 
known proteins containing cysteine residues and depends on non-specific binding to CAT 
reagents. 
From the very beginning of the proteomic era, mass spectrometry (MS) has 
played a major role in the high-throughput identification of proteins following separation 
techniques such as 2D-GE, ICAT, etc.  With the advent of the ‘soft’ ionization techniques 
such as ESI and MALDI coupled with various mass analyzers including the ion trap, 
time-of-flight (TOF), quadrupole and Fourier transform ion cyclotron (FT-MS), the 
analysis of large intact protein complexes is now possible [37], thus providing 
complementary data to that obtained by well-established methods in structural biology 
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such as electron microscopy, X-ray crystallography and NMR. Another MS-based 
technology for quantitative analysis of protein mixtures is known as the surface-enhanced 
laser desorption ionization-time of flight (SELDI-TOF) [38]. This technique utilizes 
stainless steel or aluminum-based supports, or chips, engineered with chemical or 
biological bait surfaces that allow differential capture of proteins (based on the intrinsic 
properties of proteins).  After the removal of non-specifically adhered proteins, the bound 
proteins are laser-desorbed and ionized for MS analysis.  This field is currently being 
developed as a prominent technique when combined with advances in protein chip 
technology.  
1.3 Activity based protein profiling  
As far as most enzymes are concerned, the overall protein expression levels do 
not strictly comparable to their activity profiles. Different enzymes have intrinsically 
different catalytic activities. Moreover, various post translational modifications such as 
phosphorylation, glycosilation, acteyilation etc, action of endogeneous 
activators/inhibitors, factors like pH and other native conditions significantly influence 
catalytic activity of enzymes. Most of the aforementioned methods, like 2DE-MS, still 
focus on measuring the changes in protein abundance and hence provide only an indirect 
estimate of dynamics in protein function. Undeniably, several important forms of post-
translational regulation, as well as protein–protein and protein–small-molecule 
interactions [39], may escape detection by these proteomic methods. In order to 
accomplish the functional analysis of proteins, a number of proteomic methods have been 
introduced in the past aiming to characterize the activity of proteins on a global scale. 
Large-scale yeast two-hybrid screens [40, 41] and epitope-tagging immunoprecipitation 
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experiments [42, 43] are some of the methods which are widely used to study protein-
protein interactions. Although these methods do have the benefit of assigning specific 
molecular functions to individual protein products, they normally depend on recombinant 
expression of proteins in non-natural environments and, therefore, do not directly 
evaluate the functional state of these biomolecules in their native settings.  
Recently developed activity-based protein profiling (ABPP) has opened up new 
ways of answering some of the challenges associated with proteomic research. The 
activity/affinity-based methods make use of small molecule/peptide based chemical 
probes to profile the functional state of enzyme families directly within a complex 
proteome. These probes are developed using tools of synthetic organic chemistry and 
have become a major attraction in the field of high-throughput functional proteomics.  
Originally developed by Cravatt et al., ABPP allows the proteases present in a crude 
proteome to be studied on the basis of their enzymatic activities rather than their relative 
abundance [44-49]. The major advantage of the protein activity-based chemical 
approaches for profiling proteins includes the ability to target low abundance and 
membrane associated proteins with samples of high complexity. The strategy is able to 
bridge the gap between technologies such as the protein microarray and 2D-GE based 
techniques which study endogenous proteins by their expression, and combine the high-
throughput feature of 2D-GE with the ability of function-based protein studies. The 
general strategy in activity-based profiling typically involves a small molecule-based, 
active site-directed probe which targets a specific class of enzymes based on their 
enzymatic activity. Thus, the activity-based approach can potentially filter out proteins 
that are not of interest and focus on certain classes of proteins. For example, Fig. 1 shows 
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a general approach to activity-based enzyme profiling using a fluorescent activity-based 
probe. Among the different enzymes present in a complex proteome, the probe 
selectively labels a particular class of active enzymes. The labeled enzymes can be 
separated by SDS-PAGE and visualized by fluorescent imaging, which could be further 
characterized by mass spectrometry.  
 
Fig. 1 Schematic representation of activity-based profiling strategy 
1.3.1 Activity-based probes 
Activity-based probes are designed based on their potential application in 
proteomics. The design of these probes depends largely on the nature/complexity of the 
system we are looking at as well as the type of information we intend to gather. Highly 
specific probes offer invaluable insights into the topology of the enzyme active site and 
the catalytic mechanism of a particular enzyme/sub-class of enzymes. Hence they are 
very useful in the design of specific inhibitors. On the contrary, broad-spectrum probes 
can label most proteins having the same kind(s) of activity and hence find more 
application in high-throughput activity/affinity based profiling of different classes of 
enzymes on a global scale. They typically are suicide/mechanism-based or affinity-based 
chemical probes which get covalently attached to particular classes of enzymes, thus 
allowing for the large-scale protease identification, characterization, as well as 
























activity-based, their function in enzyme profiling is however intimately associated with 
the catalytic activity. The design template for activity-based probes generally comprises 
of a reactive unit, a linker unit, and a reporter unit. 
  
 
     Tag                                   Linker                                       Reactive unit 
Fig. 2 General structure of an activity-based probe 
Reactive unit 
The reactive unit can be a suicide/mechanism-based inhibitor of one particular 
class of enzymes. By reacting with the targeting enzymes in an activity-dependent 
manner, the reactive unit serves as a “warhead” to covalently modify the enzyme 
rendering the resulting probe-enzyme adducts easily distinguishable from other 
unmodified proteins. The chemical groups on reactive units may be fine tuned to target 
different classes of enzymes based on their intrinsic activity even in the complex cellular 
environment. If the reactive unit modifies the enzyme through an affinity interaction, the 
probe is called an affinity-based probe. Such interaction does not require the enzyme to 
be fully active although these probes also target the active-site of the enzyme.  
The reactive units used in ABPP are mostly derived from enzyme inhibitors, and 
are usually electrophilic chemical groups. For cysteine proteases, a number of probes 
containing reactive units such as vinyl sulfones [51, 26, 27], epoxides [52, 53, 54], α-halo 
or (acyloxy) methyl ketone substituents [28, 55, 56] etc have been reported. Probes with 
sulfonate esters as reactive units can target different classes of enzymes such as thiolases, 
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aldehyde dehydrogenases, epoxide hydrolases and so on. Probes conjugated to p-
hydroxymandelic acid specifically label protein phosphatases [24, 57, 58] and 
hydroxamate based probes target metalloproteases [22]. 
Fluorophosphonate/fluorophosphate derivatives have been developed for selectively 





















sulfonate ester  
Fig. 3 Examples of reactive units used for activity based profiling 
The linker unit 
The linker unit forms a bridge between the reactive unit and the tag unit. The 
main purpose of having a linker is to minimize the binding interference of the tag to the 
enzyme. In other words, the linker unit functions as a spacer of appropriate length which 
allows the reactive unit to access the active site freely without considerable steric 
hindrance from big reporter units. Different types of linkers can be used based on the 
polarity of the active site of the target enzyme. Enzymes having hydrophobic residues in 
their active site are easily accessed by probes with long alkyl chain as linker. Similarly 
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PEG linker can be used when polar residues are present in the active site. Thus the linker 
can actually enhance reactive unit-enzyme binding. The linker can also convey specificity 
elements to target the probe to a particular family of enzymes. A linker can function as a 
recognition unit when it is a peptide fragment which could define differential specificity 
of the probe towards different enzymes of the same class. Since an alkyl chain does not 
impart this kind of specificity, it is often found to be useful in the design of activity based 
probes for general profiling experiments e.g., targeting all the enzymes in the same class. 
The non-specific linkers are more commonly used in large-scale protein profiling 
experiments whereby many different enzymes in the same class are analyzed 
simultaneously. Recently photo-cleavable linkers are also developed which facilitates 
quantitative proteome analysis [59]. Upon irradiation, the linker gets cleaved, releasing 

















Polyethene linker       Alkyl linker                         
Fig. 4 Examples of linkers used for activity-based profiling 
The reporter unit  
The reporter unit in the probe is either fluorescent/radio tag for sensitive and 
quantitative detection of labeled enzymes or an affinity tag which facilitates further 
protein enrichment/purification/identification. The tags must be compatible with standard 
SDS-PAGE techniques which allow for the simplest and inexpensive methods for protein 
separation and analysis. Biotin and its derivatives are the most commonly used affinity 
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tags upto date. Biotin facilitates detection by simple Western blot approaches using 
reporter avidin molecule in place of a standard antibody. After biotin labeling, the protein 
can also be isolated from the crude cell lysate, enriched and purified by streptavidin-
agarose beads and subsequently identified by Mass spectrometry. This strategy is well-
suitable for the isolation of active enzymes that are present only in low abundance. When 
compared to affinity tags, fluorescent tags and radioactive tags offer high sensitivity for 
the detection experiments and are also much faster. They can be visualized by direct 
scanning of gels under a fluorescent scanner/phosphoimager. The commonly used 
fluorescent tags are cyanine dyes such as Cy3 and Cy5, fluorescein, rhodamine, BODIPY 
etc. Each of these tags have a distinct color which makes them suitable for potential 
multicolor labeling experiments where a mixture of probes with different fluorescent 
units can be used to target different classes of enzymes in the same proteome, or the same 

























Fig. 5 Examples of reporter tags used for activity-based profiling 
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1.3.2 A few developments from our lab using activity-based/affinity-based 
approaches 
One of the major advantages of the ABPP method is that it allows the selective 
detection of targeted proteins from a group of unknown proteins spotted as arrays when 
incubated with potential ligands. Thus the whole process of separating and identifying 
proteins in a complex mixture can be simplified, by focusing on to specific targeted 
proteins. Several types of probes have been developed that target different classes of 
proteins on the basis of their enzymatic activities [23-28].  Small molecule probes derived 
from mechanism-based suicide inhibitors (Fig. 6a) had previously been reported only in 
gel-based methods for the global analysis of enzyme expression and functions [5]. By 
covalent modifications of target enzymes in a highly selective manner, these probes 
facilitate identification and/or purification of proteins from complex proteomes.  As 
depicted in Fig. 6b, we successfully extended this activity-based enzyme profiling 
approach to protein microarray [15]. Incubation of these probes with an enzyme array 
leads to its reaction with the immobilized enzymes by virtue of their activity against the 
inhibitors.  Because the probes are pre-labeled with a fluorescent dye, the formation of 
covalent enzyme-inhibitor adducts renders the enzymes detectable. This strategy was 
successfully carried out with a protein microarray immobilized with different classes of 
enzymes, including phosphatases, cysteine proteases, serine hydrolases etc. using a panel 
of different mechanism-based probes. The method allows sensitive detection of enzyme 


















































Fig. 6 (a) The principle of activity-based detection of enzymes in a microarray (b) The 
mechanism-based probes used for detection of phosphatases (PT-Cy3), cysteine (VS-Cy3) and 
serine (FP-Cy3) proteases  
 Affinity-based approaches have also been developed to profile those classes of 
enzymes which are inaccessible by activity-based profiling approaches [22]. The strategy 
takes advantage of the reversible inhibitor of an enzyme which functions as the “Trojan 
Horse”: it first ferries the photolabeled affinity probe to the enzyme active site. Upon UV 










a covalent enzyme-probe adduct, which renders the enzyme distinguishable from 
unlabeled proteins (Fig. 7).  
 
Fig. 7 The strategy for photoaffinity labeling 
Another technique termed “expression display” for the genome-wide 
identification of enzyme activities have been developed recently in our lab which 
combines the advantages of activity-based enzyme profiling with two other techniques-
ribosome display and DNA microarray [11].   
1.4 Combinatorial peptide libraries  
The peptide libraries from the polymeric beads and the peptide microarray have 
been successfully used for the screening of peptide ligands, enzyme substrates and 
inhibitors. A significant portion of the work presented in this thesis focuses on the 
synthesis and application of the prepared peptide libraries for fingerprinting experiments 
in microplate/gel-based formats. To map the substrate specificity of various classes of 
proteases a sixty-member positional scanning peptide library was synthesized as 
illustrated in chapter 3. A library of positional scanning peptides was synthesized for the 
activity-based fingerprinting studies of cysteine proteases as discussed in chapter 4. 




another positional scanning peptide inhibitor library. Some of these libraries are modified 
with functionalities so as to make them chemoselectively immobilizable on suitably 
functinalized slides for potential microarray-based screening experiments. 
1.4.1 Peptide Library on Solid Support 
Recent developments in the discovery of novel drug targets based on the benefits 
of human genome projects as well as the continued improvements in peptide delivery 
technologies have created an increasing demand for highly effective synthetic peptide 
library systems. Combinatorial chemistry has been utilized as a valuable method for the 
generation of synthetic peptide libraries. Combinatorial chemistry is a technology for 
constructing a large number of diverse compounds simultaneously and rapidly screening 
them for one or more compounds with desired properties. Even billions of different 
oligopeptides can be synthesized at the same time by combinatorial technologies. Such 
peptide libraries can be used to screen enzymatic substrates/inhibitors or cell 
binding/catalytic peptides.  In contrast to the conventional synthetic way of handling one 
molecule at a time, combinatorial chemistry has been considered as an important tool for 
the identification of new drug candidates and catalysts. Particularly solid-phase peptide 
synthesis method, developed by Merrifield et al., has become a mile-stone for the 
development of combinatorial chemistry [60]. As scientists are now demanding for more 
efficient synthetic techniques and rapid screening methods, vast areas of research such as 
discovery of new solid supports and different types of linkers, peptide coupling protocols, 
semi/fully automated synthesis systems, and screening methods have been developed. 
Solid-phase peptide synthesis methods allow for the reproducible production of libraries 
of millions of potential substrates in a defined manner. With recent developments in the 
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chemoselective chemistries and the surface modification technologies, peptide library 
synthesis in a microarray format has become a common tool for high-throughput 
screening. The conventional methods of peptide library synthesis on polymeric supports 
can be classified into three groups: parallel synthesis, split and mix synthesis and reagent 
mixture synthesis. 
1.4.2 Parallel synthesis  
In this method, the synthesis and screening of peptide libraries are performed in parallel. 
Geysen and coworkers reported the classic peptide library synthesis by multi-pin 
technology [61]. Peptide libraries are synthesized in individual reaction vessels, and 
therefore, all the products are pure, separated and well defined. However, this method 
generates relatively small set of peptides in one batch especially when they are 
synthesized in a 96-well-plate format. As a result, an automated system is mandatory for 
the generation of a large pool of peptides. 
 
Fig. 8 Schematic representation of parallel synthesis 
Split Reaction Split Reaction 
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1.4.3 Split and mix synthesis  
The split and mix synthesis can provide libraries which are equimolar mixture of 
random and large peptides. The method consists of three processes: splitting, coupling 
and mixing. At first, the resin beads are split into multiple reaction vessels. The coupling 
is carried out with different individual compound units. After the reaction, the polymer 
beads are randomly mixed. Such splitting and mixing are done alternatively. A large 
number of peptide sequences can be obtained by repetiting many cycles of the 
aforementioned procedure. This split and mix synthesis method has been found more 
useful and easier when compared to the parallel synthesis for generating equimolar large 
peptide libraries [62-65]. Using this method, the peptide libraries can be obtained in such 
a way that each bead can display only one peptide. This one-bead one-compound 
(OBOC) combinatorial library can be screened for desired biological properties using on-
bead or solution assays. 
 








1.4.4 Reagent mixture synthesis  
The reagent mixture synthesis method is a more convenient method than the split 
and mix synthesis method for the preparation of larger peptide libraries. A mixture of all 
the selected amino acids can participate in the coupling reaction as building blocks in a 
single reaction vessel. To compensate for the different reaction rates of each amino acid 
reagent, isokinetic ratios are calculated and the corresponding amounts of each amino 
acid reagent are employed in the coupling reactions. Ostresh et al. performed the reagent 
mixture synthesis by calculating isokinetic ratios of tert-butyloxycarbonyl (Boc)-amino 
acid [66]. However, this method cannot be applied to one-bead one-compound 
combinatorial library synthesis since each single bead might contain a mixture of peptide 
products. Nevertheless, the reagent mixture synthesis as well as the split and mix 
synthesis are useful for the preparation of positional scanning libraries. 
1.4.5 Screening positional scanning peptide libraries 
Synthetic combinatorial peptide libraries in positional scanning format (PS-SCL) 
have emerged as a useful tool for the identification of active compounds from huge 
libraries made up of millions of compounds. Selective inhibitors and probes are of 
considerable use for the deconvolution of the protease or proteosome’s role in a wide 
range of biological processes [67-69]. The design of potent and selective inhibitors is 
largely dependent on the determination of enzyme substrate specificity [70]. The 
screening of PS-SCLs, in most instances, allows for the identification of the most active 
amino acids at each position of a peptide in a single assay [71, 72]. A positional scanning 
library is usually a peptide-based small molecule library where each amino acid residue 
of the peptide would occupy the binding pocket of the enzyme, mimicking the enzyme-
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substrate interaction [73]. By varying one of the substrate residues with different amino 
acids, while keeping other positions constant, this library of compounds would react with 
the enzyme at different rate and extent. The resulting data can be used to generate an 
affinity fingerprint of these small molecules, which provides a rapid visual readout of 
enzyme active site topology [74]. 
PS-SCLs are free to interact in solution, and therefore can be screened in virtually 
any assay system for quick identification of compounds. A PS-SCL made up of 
hexapeptides consists of six separate positional libraries, each composed of mixtures 
having a single position defined with an amino acid and the remaining positions as 
mixtures of amino acids. Fig. 10 demonstrates hexapeptide libraries for positional 
scanning. ‘O’ is a residue that is known within the mixture as one of the monomers used 









Fig. 10 A schematic representation of positional scanning library 
 
1.5 Bioimaging  
   Analytical techniques that allow the visualization and quantitation of proteins, 
including enzymes, in living cells is essential to study their structure and functions within 
the biological context. The early development of bioimaging was based on the 
 19
fluorescent proteins and other molecular labels which gave a better understanding of 
intracellular proteins and subcellular events. Together with the advancement in 
fluorescence and confocal laser scanning microscopies (CLSM), 3D imaging of the 
cellular events and protein dynamics can now be detected in real time within living cells 
[75]. However, the main drawbacks of GFP-like proteins include their large size, obligate 
oligomerization, and sometimes slow or incomplete maturation.  Ideally, a good protein 
labeling strategy should satisfy the following criteria: (1) possesses a high signal-to-noise 
ratio (i.e. high specificity for target protein); (2) upholds the integrity of the labeled 
protein; (3) does not interfere with the biochemical functions or cellular localization of 
the labeled protein, and (4) has minimal perturbation to the normal cellular processes. 
Many of these could be met by small molecule-based labeling strategies, which in recent 
years have become increasingly feasible for bioimaging experiments, as a result of 
advances in the synthesis of novel fluorescent dyes, as well as the development of new 
bioconjugation strategies which allow for highly specific and efficient incorporation of 
molecular probes to proteins expressed in live cells [76, 77].  Since the probes used for 
protein labeling in these strategies are typically small, they likely do not perturb the 
function of the labeled protein, thus making them attractive over FP-based strategies.  
Some of the small molecule-based protein labeling techniques developed in recent years 
hold great promises in future high-throughput protein analysis in live cells.       
 A few groups, including our own, have developed novel strategies for specific 
labeling of proteins with small molecular probes in live cells.  Different reported 
strategies are based on unique chemistries and bio-interactions.  Of different small 
molecule probes used, a number of criteria should be carefully considered, including their 
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cell permeability, cytotoxicity, specific reactivity, good fluorescent properties, etc.  The 
first innovative method for the site-specific labeling of recombinant protein with small 
organic molecules within live cells was developed by Tsien et al. [78].  Their method 
exploits the well-know specificity of organoarsenics with pairs of thiols.  Here a short 
peptide sequence CCXXCC (in which X is a non-cysteine amino acid) was genetically 
fused to the protein of interest, which was subsequently recognized and labeled by a cell 
permeable fluorescein derivative called FlAsH as shown in Fig. 11a.  The free FlAsH 
label is virtually non-fluorescent, but acquiring bright fluorescence only upon binding to 
CCXXCC motif present in the target protein.  Tsien et al. chose ECFP (enhanced cyan 
fluorescent protein) as a model protein and genetically fused a CCXXCC motif to its C-
terminus.  Upon transient expression in HeLa cells and treatments of the cells with 
FlAsH, the formation of a specifically labeled protein-small molecule complex was 
successfully detected by monitoring the fluorescence resonance energy transfer (FRET) 
from ECFP to FlAsH.  The age and life cycle of protein molecules could be studied by 
sequential labeling with differently colored biarsenical labels.  Gaietta et al. applied this 
strategy to monitor the translocation of connexin in and out of gap junctions [79].  
Another protein-labeling method was recently developed by Kepplar et al., which 
covalently labels a target protein fused to the human DNA repair protein O6-
alkylguanine-DNA alkyltransferase, or hAGT [80].  Specific covalent labeling of the 
target protein with a small molecule was achieved through the highly specific enzymatic 
reaction between hAGT and the small molecule.  The cellular role of hAGT is to 
irreversibly transfer the alkyl group from O6-alkylguanine-DNA to one of its reactive 
cysteine residues, which results in the repair of the alkylated DNA.  The authors 
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brilliantly exploited this chemistry to label the hAGT fusion protein expressed in live 
mammalian cells as depicted in Fig. 11b. 
Our group has developed a novel strategy for site-specific covalent labeling of 
proteins in vivo.  In our strategy, a protein of interest bearing an N-terminal cysteine is 
expressed inside a live cell by intein-mediated protein splicing.  We selected the 17 kDa 
Ssp DnaB mini intein, whose splicing activity was genetically engineered to occur 
efficiently under physiological conditions, to generate an N-terminal cysteine in the target 
protein.  Chemoselective native chemical ligation reaction between the thioester- 
containing probe and the N-terminal cysteine of the protein under physiological cellular 
conditions results in the specific protein labeling as given in Fig. 11c.  Our strategy 
provides a simple way of site-specifically labeling proteins in live cells, with little 
modification to the original protein apart from the addition of at most a few extra amino 
acids.  We have successfully shown its utility in specific covalent labeling of proteins in 
bacteria as well as in mammalian cells [81].   
Recently, our group developed a proteomic method that allows identification of 
caspases and their associating proteins [82].  We found that efficient in vivo labeling of 
caspases expressed inside apoptotic HeLa cells could be achieved using 
fluoromethylketone (fmk)-containing, activity-based small molecule probes (discussed in 
chapter 2).  
More recently, our group designed two probes for the specific labeling of His-tag 
proteins expressed in live cells (discussed in chapter 5). The probes consist of a 
chromophore and a metal ion chelating to the nitrilotriacetate (NTA) moiety. The 
labeling is based on the non covalent interaction between the oligohistidine sequence and 
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the NTA moiety.  While our work was going on, Vogel et al. reported a generic method 
for the site-selective and reversible labeling of membrane proteins containing a 
polyhistidine sequence in live cells with NTA containing probes [83] Fig. 11d. 
  A separate method developed by Tsien’s group takes advantage of the very high 
affinity of avidin for its small molecule ligand, biotin (10-15 M) [84]. In their approach, 
avidin functions as the genetically encoded tag and the derivatized biotin acts as the label.  
The luminal pH of specific organelles expressing an avidin-fused protein was 
investigated using a cell-permeable, pH-sensitive fluorescein-biotin derivative.   
Another strategy involving the selective binding of a chemical ligand to a receptor 
protein is based on the hapten-antibody interaction. A membrane-permeant 
phenyloxazolinone hapten conjugated to a pH-dependant fluorescent dye was trapped by 
a single chain antibody that had been expressed in the lumen of the organelles and used to 
study pH regulation in different compartments along the cellular secretory pathway [85]. 
The noncovalent interaction between dihydrofolate reductase (DHFR) and 
methotrexate (Mtx)-containing small molecule derivates is a good alternative to avidin-
biotin and hapten-antibody interactions as shown in Fig. 11e. The Cornish group very 
recently exploited this binding as a generic method for in vivo labeling of DHFR-fused 
proteins using fluorescent, small molecule probes conjugated to Mtx [86].  They were 
able to successfully label DHFR-fused proteins targeted to the nucleus and plasma 
membrane in DHFR-deficient CHO mammalian cells. 
Inteins are internal polypeptide sequences that are posttranslationally excised 
from a protein precursor by a self-catalyzed protein-splicing reaction.  The result is the 
concurrent ligation of the two flanking polypeptides sequences to generate a mature, 
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functional protein.  In recent years, intein-based labeling methods have become an 
important technique in protein engineering [87].  Recently, Muir’s group developed a 
novel strategy to specifically incorporate a synthetic molecule into a protein in vivo by 
utilizing trans-splicing inteins, in which the intein is split into two pieces and its activity 
is subsequently regained upon reconstitution of these fragments [88].  By exploiting this 
technique, his group was able to successfully label GFP with a FLAG epitope inside live 
mammalian CHO cells.  
Pioneered by the Schultz group, the suppressor tRNA technology was an 
ingenious and promising technique that enables the incorporation of unnatural amino 
acids into proteins during in vitro transcription/translation reactions [89].  Recently, 
Zhang et al. designed and utilized an orthogonal tRNA-TyrRS pair that selectively and 
efficiently incorporated the unnatural amino acid, m-acetyl-(L)-phenylalanine, into a 
protein overexpressed in E. coli, and successfully introduced a “ketone handle” into the 
target protein [90].  This protein was subsequently modified, in living cells, by hydrazide-
containing small molecules using the ketone/hydrazide chemistry, demonstrating for the 
first time the potential use of tRNA technology for live cell bioimaging purposes.  The 
labeling reaction was selective, and in general proceeded with relatively good yields (e.g. 

















































































X = Biotin or Hapten or Methotrexate







Fig. 11 (a) The site-specific labeling of tetracysteine motif by FlAsH (b) Mechanism of labeling 
of hAGT fusion proteins with BG derivative (c) The labeling mechanism of thioester probe with 
the N-terminal cysteine proteins in live cells (d) The NTA probe coordinating to Ni (II) ion (e) 









Chapter 2 Design and Synthesis of activity-based probes targeting 
caspases  
2.1 Introduction  
The present chapter illustrates our efforts towards the design and synthesis of 
fluoromethyl ketone-based small molecule probes to specifically target caspases. 
2.1.1 Caspases 
The cysteine proteases can be categorized into many different classes based on the 
structural diversity of their sub-sites, the major families being the papain superfamily and 
the caspases. Caspases are enzymes which play a key mediating role in apoptosis, or 
programmed cell death [91-93]. The involvement of caspases in apoptosis was originally 
established by Robert Horvitz and colleagues in 1993. They found that ced-3 gene was 
required for the cell death that took place during the development of the nematode C. 
elegans and the protein encoded by the ced-3 gene was a cysteine protease with similar 
properties to the mammalian interleukin-1-beta converting enzyme (ICE), now known as 
caspase 1. Following this discovery, the other mammalian caspases, in addition to 
caspases in other organisms such as the fruit fly drosophila melanogaster, were soon 
identified and characterised. The caspases are named by the order in which they were 
identified.  
The name “caspase”, comes from the term “Cysteine-dependant, Aspartate-
SPecific proteASES”, reflects the observation that all caspases catalyze proteolysis by 
using an active-site cysteine residue, and are characterized by their unique requirement 
for an aspartic acid at the P1 position of the substrate cleavage site. Besides the stringent 
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requirement for cleavage after aspartic acid residues, a recognition sequence of at least 
four amino acids N-terminal to the cleavage site is preferred for efficient catalysis. 
Caspases may be classified, according to their functions, into two groups [94]: 
Group I (caspase-1, 4, 5, 11-14), involved in processing pro-inflammatory cytokines. 
Group II (caspase-2, 3, 6-10), involved in apoptosis. Group II can be subdivided into 
“initiators” (caspase-2, 8-10), involved in upstream regulatory events of the apoptotic 
cascade and “effectors” (caspase-3, 6, 7) which are directly responsible for proteolytic 
cleavages leading to cellular breakdown. Activation of the “initiators” would trigger the 
apoptotic cascade to activate the downstream “effectors” [95]. Once activated, these 
effector caspases would carry out proteolytic cleavages to bring about apoptosis, a 
cellular process indispensable for animal development and tissue homeostasis.  
Though there are caspase-independent pathways to apoptosis, caspase regulation 
is still vital in maintaining appropriate apoptosis. Various stimuli, including cytokines, 
hormones, viruses, toxins, chemicals and UV have been shown to trigger apoptosis of 
normal cells, whose initial sign was characterized by morphological changes of cells, 
followed by a number of intracellular biochemical changes, leading to the activation of 
caspases. Insufficient caspase activity promotes cell accumulation which may cause 
cancer and autoimmune diseases, while excessive caspase activity could lead to 
accelerated cell death, believed to result in neurodegenerative disorders such as 
Huntington’s and Alzheimer’s diseases [93, 96].  
Given their pivotal role, caspases are attractive therapeutic targets for treatment of 
these conditions. It is hence in our interest to discover new caspases, and to design 
 27
therapeutic drugs to target caspases and their regulation. In this project, the focus would 
be placed on Group II caspases involved in apoptosis.  
2.1.2 Mechanistic details of interaction of caspases with their substrates 
The caspase active site has a positively charged S1 subsite which can bind to the 
negatively charged P1 aspartate. Conserved in all caspases is also a highly restrictive 
pocket, which contains three residues: Arg179, Gln283 and Arg341. The carboxylate of the 
P1 aspartic acid fits into this pocket and forms hydrogen bonding interactions with the 
three residues [91]. These pocket and interactions are the reasons for the strict specificity 
for P1 to be an aspartic acid. The S2 and S3 subsites are more tolerant for different amino 
acids. The S4 binding site is the primary determinant for substrate specificity among 
different caspases members. In the catalytic mechanism of caspases [97], the Cys285 thiol 
side chain is first polarized by the imidazole group of His237 in the catalytic dyad. The 
activated Cys285 thiol then acts as a nucleophile to attack the carbonyl carbon of the 
amide bond that is to be cleaved, forming a tetrahedral substrate intermediate. The 
oxyanion of the substrate interacts with the backbone amide protons of Cys285 and Gly238. 
His237 participates in general acid catalysis of acyl-enzyme formation by protonating the 
























































Fig. 12 The catalytic mechanism of caspases 
2.2 Affinity tag approach to develop caspase probe for an in vitro proteomic 
experiment 
Thus far a number of methods have been developed to identify new caspases and 
their interacting proteins (e.g. caspase substrates) [98-100], including cDNA pool 
expression strategies, two-hybrid approaches and two-dimensional gel electrophoresis 
(2D-GE), just to name a few. Among them, the 2-D approach,  in which global proteomic 
profiles of normal and apoptotic cells were compared, often generates a few hundreds of 
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candidate protein spots, the majority of which are proteins unrelated to apoptosis. This 
thus makes it difficult, as well as impractical, to be used in large-scale studies of proteins 
interacting/associating with caspases during apoptosis. Already researchers are 
developing new methods to simplify protein analysis and allow high-throughput 
screenings. The activity-based, affinity tag approach can potentially filter out proteins 
that are not of interest and focus on certain classes of proteins (e.g. based on activity) [45-
49], while protein chips and microarrays offer the attractive prospect of screening 
thousands of proteins simultaneously [17, 101-103]. Unknown proteins could be spotted 
on arrays and incubated with potential ligands, which bind and allow the detection of the 
target proteins. The whole process of separating and identifying proteins in a complex 
mixture hence may be simplified, by zooming in only onto specific target proteins. Our 
caspase probe is meant for selectively targeting all caspases in a single proteomic 
experiment. The probe is made up of three parts (for schematic representation of a typical 
activity based probe, refer Fig. 2, chapter 1): (1) a fluoromethyl ketone (FMK)-
containing unit which specifically modifies the active site of caspases in an activity-
dependent manner, (2) a simple alkyl linker as spacer and (3) a fluorescent tag for easy 














Fluorescent  unit Linker Reactive unit 
Fig. 13 Structure of the caspase-Cy3 probe 
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2.2.1 Design of the caspase-Cy3 probe 
Reactive unit 
The halomethyl ketones have been known as cysteine protease inhibitors for a long time. 
The chloromethyl ketones were found immensely suitable in elucidating the binding 
requirements and chemically reactive residues of the active sites of serine and cysteine 
proteases [104,105]. The peptide diazomethyl ketones, which are the precursors of the 
chloromethyl ketones, are themselves potent irreversible inhibitors of cysteine proteases 
[106-108]. However, there were potential problems with using these inhibitors as drugs 
since they are relatively strong electrophiles and may indiscriminately alkylate serine 
proteases, as well as other SH-containing molecules such as glutathione and non-
proteolytic enzymes and hence unsuitable for in vivo applications. There are two possible 
pathways [109] as shown in Fig. 14: (A) the thiolate anion can react directly with the 
carbon of the chloromethyl group in a nucleophilic substitution; (B) the sulfur attacks the 
carbonyl carbon and the product is formed via a tetrahedral intermediate and a sulfonium 
ion in a 3-center reaction. According to this second mechanism, the peptidyl halomethyl 
ketone would be a “mechanism-based inhibitor” instead of an “affinity label”, since the 
first step, the formation of the tetrahedral intermediate, is part of the “normal” catalytic 
pathway. The FMK derivatives are believed to inhibit caspases exclusively following the 
second pathway since fluoro compounds are much poorer alkylating agents compared to 
the analogous chloro derivatives. The difference in their reactivity is mainly attributed to 
the much stronger bond between fluorine and carbon when compared to other halogen-
carbon bonds. Thus, use of fluoromethyl ketone may significantly reduce nonspecific 
alkylation. In addition, fluorine activates the carbonyl carbon towards nucleophilic attack 
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more than chlorine. Thus among the α-substituted ketones, fluoromethyl ketones are 
well-documented examples to covalently react with the active site residues in many 
cysteine proteases [109,110]. Hence, the fluoromethyl ketone was chosen as the 
electrophilic moiety in the aspartic acid analogue reactive molecule for caspases in our 
























Fig. 14 The proposed inhibition pathways for halomethyl ketones 
Linker  
Peptide fragments are often used to improve the selectivity and potency of the 
probe towards individual caspases since the preferred tetrapeptide recognition motif 
differs significantly among caspases. Anyway, since multiple caspases are activated in a 
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typical apoptosis pathway, a broad-spectrum caspase inhibitor would be more effective to 
inhibit most of the caspases and thus achieve maximum inhibition of apoptosis when 
compared to a specific inhibitor to any particular caspase. Hence we chose to design a 
general caspase probe capable of detecting caspases selectively over other non-caspase 
enzymes. A linker unit consisting of a simple alkyl chain as shown in Fig. 15 was chosen, 
which is approximately the length of the P2-P4 tripeptide sequence in a typical caspase 

































Fig. 15 Comparison of the length of the alkyl linker with that of the P2-P4 tripeptide sequence of 
a typical tetrapeptide FMK inhibitor 
 
Fluorescent tag 
 The carboxymethyl cyanine dye Cy3 was chosen as the reporter unit in our probe 
due to the relative ease of preparation, higher extinction coefficients and quantum yields 
of cyanine dyes. Cyanine dyes can be readily converted to succinimidyl esters to form 
amide linkages with the linker unit. Moreover, studies have shown that the separation of 
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the chromophore with the reactive carboxylic acid group by the methylene bridge 
minimizes the changes often observed in spectral properties of a probe as a result of the 
labeling reaction. Cyanine dyes are usually named according to a reference system 
devised by Waggoner et al. [111]. “Cy” indicates that the compounds are cyanine dyes. 
The number which follows immediately gives the number of carbon atoms in the 
polymethine chain. Cyanine dyes are superior to other fluorescent dyes, such as 
fluorescein and rhodamine, as they possess greater photostability and higher water 
solubility, making them suitable for labeling reactions in aqueous biological media [112]. 
Most importantly they fluoresce in spectral regions (500nm to beyond 750nm) away from 
the autofluorescence of biological systems which usually occurs at shorter wavelengths 
(300-500nm). Furthermore, they are relatively pH-insensitive over a broad range so that 
fluoresecence can be maintained at physiological pH. 
2.2.2 Chemical synthesis of the caspase-Cy3probe 
A versatile method to synthesize fluoromethyl ketone moitey was first reported by 
Imperiati et al. [113]. The synthesis is based on the recognition of β-amino alcohols as 
the basic building blocks of a fluoromethyl ketone moiety. The amino alcohols were 
prepared from the corresponding nitroalkane and the appropriate fluorinated aldehyde 
hydrate or hemiacetal in a two-step procedure.  
Later, the strategy was modified by Revesz and colleagues [114] to a more 
general and convenient synthetic approach. Instead of using the fluorinated aldehyde 
hydrate/hemiacetal as the starting material, the authors successfully generated the 
aldehyde in situ from the corresponding alcohol. We decided to employ this method for 
the synthesis of fluoromethyl ketone unit in our probe.  
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Initial attempted synthesis of the probe indicated that the fluoromethyl ketone 
group in the probe is a potential complication as the presence of fluorine increases the 
electrophilicity of the carbonyl carbon [115]. Together with its acidic proton, the 
fluoromethyl ketone is rather susceptible to reactions involving bases and nucleophiles, 
which can lead to dimerization, epimerization and Schiff base reactions [116]. Therefore, 
a synthetic route (Scheme 1) was devised, in which reactions involving the use of 
potential nucleophiles and strong bases were intentionally avoided. Strategically, the 
oxidation of the alcohol to generate the FMK group was left to the final steps.  
Briefly, the t-butyl ester of 3-nitro-propionic acid, 1, was generated from 3-nitro-
propionic acid using the classical isobutene/concentrated acid approach [117]. 
Fluoroacetaldehyde, generated in situ by oxidation of fluoroethanol under Swern 
Conditions [118], was then added to 1 to yield the key intermediate 2 via a nitro-aldol 
reaction. Hydrogenation of 2 over freshly prepared Raney nickel catalyst [119] gave 
aminoalcohol 3 in 73% yields. The precursor of reactive unit, the amino-alcohol was 
reacted with succinic anhydride to give the acid 4. The singly Boc-protected 
ethylenediamine, prepared as previously reported [120], was coupled to 4 using standard 
coupling reagents. Swern oxidation of the resulting compound 5 yielded 6, which was 
subsequently treated with 50% TFA to give 7. Conjugation of the dye molecule, Cy3, to 
the probe was carried out by coupling 7 with the NHS ester of Cy3, 8.  The final probe 9 
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Scheme 1 The synthetic route for FMK-Cy3 probe 
The synthesis of Cy3 was achieved via a three step pathway, according to 
reported literature procedure [121]. The first step involves the nulceophilic substitution of 
bromovaleric acid by 2, 3, 3-trimethylindolinium to give intermediate 10 in 47% yield. In 
the second step, 1, 2, 3, 3-tetramethyl-3H-indolinium iodide reacted with N, N’-
diphenylformamidine to afford the second intermediate, 11. Cy3 (12) was obtained in 
44% yield from the reaction of 10 with intermediate 11 in the presence of potassium 
acetate and sodium iodide. The NHS ester of Cy3 can be synthesized from Cy3 using 
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Scheme 2 The synthetic route for Cy3-NHS  
2.2.3 Results and conclusions of the in vitro experiments  
The probe was tested for selective labeling of proteins based on their enzymatic 
activity. The results from the in vitro labeling experiments demonstrated that the probe 
exhibits strong chemical reactivity towards caspase-1 over other enzymes tested. 
Preliminary assays and proof-of-concept experiments using this probe were done by a 
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fellow colleague and hence the details of the experiments are not described herein. Only 
the key observations and final results are given (for experiment details, refer [28]).   
 
 
Fig. 16 SDS-page results of labeling using the caspase-Cy3 probe 
List of enzymes (Sigma Catalog c).(a): (1) α-chymotrypsin (C-4129), (2) β-chymotrypsin (C-
4629), (3) γ-chymotrypsin (C-4754), (4) chymotrypsinogen (C-4879), (5) pepsin (P-6887), (6) 
proteinase K (P-6556), (7) subtilisin (P-5380), (8) trypsin inhibitor (T-9378), (9) trypsinogen (T-
1143), (10) trypsin (T-1426), (11) thrombin (T-4648), (12) BSA (A-2512), (13) lysozyme (L-
6876), (14) phosphatase, acid (P-3627), (15) phosphatase, alkaline (P-7640), (16) phosphatase, 
alkaline (P-2265), (17) phosphatase, alkaline (P-4002), (18) lipase (L-1754), (19) lipase (L-3001), 
(20) lipase (L-9031), (21) protease (P-6911), (22) phosphatase, acid (P-3752). (b): (23) Caspase-
1, (24) papain (P-4762), (25) chymopapain (C-8526), (26) bromelain (B-4882). 
A panel of 22 commercially available proteins was used, none of which were 
caspases. Upon incubation with the probe for 30 min under appropriate conditions, the 
proteins were first separated using SDS-PAGE (Fig. 16a), followed by detection of 
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fluorescence labeling using a fluorescence-based gel scanner. None of these proteins gave 
any significant fluorescent bands, except for BSA, which is known to bind to many 
molecules nonspecifically. We next investigated the selective labeling of the probe 
against its targeting enzyme, caspase. Caspase-1 was incubated with probe for differing 
lengths of time and the resulting labeled reaction was analyzed by SDS-PAGE and 
fluorescence detection. In order to unambiguously confirm the selectivity of the probe 
against only caspases, three other non-caspase cysteine proteases were used as controls 
and analyzed simultaneously.  As shown in Fig. 16b, only caspase-1 was selectively 
labeled by the probe following 0.5 h incubation.  No labeling was observed for the other 
three non-caspase cysteine proteases, indicating the high specificity of this probe for the 
detection of caspase activity. As the incubation time of the labeling reaction increases 
(3.5 h), other non-caspase cysteine proteases started to react with the probe, as evidenced 
by appearance of some fluorescence bands on the gel. However, a comparatively much 
stronger band was still observed for the caspase reaction. In order to further confirm that 
the fluorescence labeling of caspase-1 by the probe is due to its enzymatic activity, the 
enzyme was first inactivated by heat, then treated with the probe followed by SDS-PAGE 
analysis. No labeling of caspase-1 was observed, indicating the enzymatic activity of 
caspase- 1 is a prerequisite for the labeling reaction to occur. 
In conclusion, the work presented in this section mainly focus on developing 
fluorescently-labeled affinity probes containing chemical reactivity specific towards 
caspases using activity based affinity tag approach. Our studies clearly demonstrated the 
potential of this probe in the selective detection of caspases over non-caspase enzymes.  
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     2.3 Activity based affinity probes for in vivo labeling of caspases 
To discover new caspases and caspase substrates as well as to design drugs to 
target caspases, it is important to have a comprehensive understanding of their functions 
and interactions in the cellular environment. This necessitates developing suitable 
probes/methods to characterize the activity of these enzymes inside the live cell. The 
previous section describes the design and synthesis of an activity-based probe that targets 
caspases specifically in vitro. We envisaged that the high specificity of this probe towards 
caspases over other cysteine and non-cysteine proteases might enable the selective 
detection of caspases in more complex systems such as mammalian cells. The present 
section deals with an extention of our activity based affinity tag approach to the in vivo 
labeling of caspases in apoptotic cells by the use of modified probes which are cell 
permeable. Collectively, the strategy we employed combines the use of activity based 
probes, 2DE-MS and mass spectrometry. We have found that our probes passively cross 
the cell membrane and effectively label caspases expressed inside apoptotic HeLa cells. 
We have identified caspase-8 in the initial round of experiments and subsequently 
discovered a few potential caspase substrates. The attractive feature of our strategy is that 
it allows for the large scale identification of novel enzyme-associating proteins. 
Previously, activity-based profiling strategies had only been developed to target different 
enzymes [122]. Our findings thus represent the first example into the study of enzyme-
associating proteins. 
2.3.1 Design of cell permeable caspase probes  
These probes differ from our previous caspase probe only in the design of reporter 
tags. Although the FMK-Cy3 probe was proven successful in our in vitro experiments, 
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the use of the same for in vivo experiments was not desirable. This was mainly due to the 
apparently impermeable nature of the probe and the relative toxicity of the Cy3 to 
biological systems. For the present studies, two novel probes were generated 
fluoromethyl ketone - Fluorescein and fluoromethyl ketone-Biotin hereafter will be 
referred to as FMK-FL and FMK-Biotin, respectively. Both fluorescein and biotin have 
previously been reported to penetrate cell membrane and facilitate in vivo labeling [80, 
84]. We envisaged that, with a small size (MW = 800 Da) and high lipophilicity, the two 
probes may easily cross the cell membrane barrier of apoptotic cells into their cytosol, 
where they would react covalently with (and subsequently be trapped by) active caspases.  
The labeled caspases may be subsequently identified by SDS-PAGE and MS analysis of 








































Fig. 17 (a) The cell permeable FMK probes (b) Schematic representation of the labeling strategy  
Initially developed activity-based probes have mostly been using either direct 
radiochemical (125I) detection [52, 123] or indirect biotin/avidin-based methods to assess 
the extent of labeling of active proteins. Together with advances in fluorescence and 
confocal laser scanning microscopies [124], 3-dimensional imagings of cellular events 
and protein dynamics have become possible in real time [125-127]. Compared to 
fluorescent proteins like GFP, small molecule probes such as fluorescein and TMR 
conjugated probes possess a myriad of advantages including ones described above, as 
well as a wide spectrum of “colors”. Their small sizes also ensure minimal perturbation 
to the labeled protein and other cellular components.  
The diacetate form of fluorescein was used instead of free fluorescein in the 
FMK-FL probe in order to enhance the cell permeability of the probe. When fluorescein 








across the plasma membrane of live cells in a passive fashion. Since most mammalian 
cells have some amount of esterase activity in the cytosol, the intracellular dye is cleaved 
back to generate the free fluorescein which is extremely fluorescent in nature. Specific 
labeling of proteins using fluorescein, coumarin, tetramethylrhodamine, 
carboxynaphthofluorescein etc has previously been reported [76, 77]. The probes 
containing these fluorophores can be used for potential multi-color labeling of proteins as 
they exhibit different colors (blue, orange and red, respectively). Cell permeability, non-
toxicity, specific reactivity and good fluorescent properties make these small molecules 
attractive alternatives to fluorescent proteins and radioactive labels for live cell imaging 
purposes.  
Biotinylated activity based probes allow for avidin-based purification of target 
proteins. However, the indirect and time consuming nature of the detection process limits 
the throughput and robustness of this method. But at the same time, the method help to 
enrich and purify labeled proteins by affinity capture with steptavidin beads which will 
provide sufficient amount of protein concentration for analytical purposes. The FMK-
Biotin probe consists of the same reactive unit to target caspases as FMK-FL, with the 
fluorescent tag unit replaced by biotin. The use of biotin as a small molecule to form non-
covalent bond with the protein that contain biotin acceptor domains has been reported in 
many instances [77, 84,128]. It has also been previously reported that both fluorescent 
and biotinylated probes mostly label similar set of proteins [129]. 
2.3.2 Chemical synthesis of cell permeable caspase probes 
5-Carboxyfluorescein (13) was generated from resorcinol and trimellitic 




After acetylating the hydroxyl groups of 5-Carboxyfluorescein by refluxing with 
acetic anhydride in pyridine, the resulting product 5-Carboxyfluorescein diacetate (14) 
was purified on Flash column chromatography. The carboxylic acid was activated by 
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Scheme 3 Synthetic route for Fluorescein diacetate-NHS  
Compound 7 was prepared from 3-nitro-propionic acid and 2-fluoroethanol in 
seven steps as described in the previous section. Probe 16 was synthesized by coupling 
the NHS-ester of fluorescein diacetate with compound 7 under standard coupling 
conditions. This coupling was carried out under mild basic conditions, by using pyridine 
as the neutralizing base instead of DIEA since the diacetate moiety was found to be 
extremely base-labile. For the same reason, base extraction (e.g. NaHCO3) in the workup 
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should also be avoided. The probe 18 was obtained by coupling compound 7 with Biotin-
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Scheme 4 Synthetic route for FMK-FL and FMK-TMR probes 
2.3.3 Results and conclusions of the in vivo labeling experiments  
Initial biochemical experiments such as checking the cell permeability of the 
probes and preliminary labeling using FMK-FL probe were done together with a fellow 
colleague in the biology department. Majority of the further experiments were done 
entirely by my colleague and hence the experiment details have not described herein. 
Only the important observations and the final labeling results are included in this draft. 
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The FMK-FL was chosen to assess its cell permeability, which may be readily 
followed by fluorescence microscopy. Two separate culture plates of HeLa cells were 
incubated with a control fluorescein dye (without the reactive unit) and FMK-FL 
followed by repeated washes with PBS buffer to remove any excessive free dyes, and 
imaged (panels i and ii in Fig. 18(a), respectively). As shown in panel ii, only cells 
incubated with FMK-FL, but not with the control dye (panel i), were highly fluorescent, 
indicating the successful entry, as well as retention of the probe, inside the live cells. In a 
separate experiment, HeLa cells were first induced by UV to become apoptotic, treated 
with FMK-FL then imaged. As shown in panel iii, the apoptotic cells, as characterized by 
their signature round shape, could be readily labeled by the probe FMK-FL and rendered 
highly fluorescent as well (panel iv). These results thus indicate that FMK-FL is indeed 
cell-permeable and able to label live cells, normal as well as apoptotic. Furthermore, the 
labeling depends greatly on the structure of the probe (i.e. the reactive unit), as the 
control dye alone did not show any labeling towards the cells.  
We next assessed whether FMK-FL and FMK-biotin can selectively label 
caspases in live apoptotic cells. Apoptotic cells were treated with FMK-FL and FMK-
biotin, respectively. As shown in Fig. 18(b), both probes showed similar labeling 
profiles. A 27 kDa band was observed in both gels as the major band in the labeling 
reaction, and was subsequently identified to be Caspase 8 – one of the endogenous 
caspases known to be activated upon cell apoptosis. 
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Fig. 18 Results of the labeling experiments with FMK-FL and FMK-biotin 
(a) Fluorescence microscopes of normal HeLa cells labelled with (i) control dye and (ii) FMK-
FL, together with (iii) phase contrast and (iv) fluorescence image of apoptotic cells labeled with 
FMK-FL. (b) SDS-PAGE of apoptotic cells labeled with (i) FMK-FL followed by fluorescence 
gel scanning and (ii) FMK-biotin followed by western blotting with anti-biotin. (c) 2D-GE of 
proteins bound to streptavidin particles upon affinity purification; circled were the ones identified 
by MS. 
We also proved that the activity-based profiling approach could be used to pull-
down caspase-associating proteins from live cells. UV-induced apoptotic cells were 
incubated with the FMK-biotin. Following extensive washings, the cells were collected, 
lysed under native conditions, and the resulting extract was purified with streptavidin 
beads. Control experiments were done simultaneously in which cell extracts without 
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probe treatment was subjected to the same affinity purification procedures. Spots 
uniquely present in the positive gel were characterized (circled in Fig. 16c). As shown in 
Table 1, out of a total of seven proteins identified, they could be broadly classified into 
three groups: (1) known caspase substrates, (2) proteins with shared homology/associated 








Table 1 Proteins identified by mass spectrometry 
In conclusion, we have developed a proteomic method that allows identification 
of caspases and their associating proteins from live apoptotic cells. We anticipate that, 
given the increasing availability of activity-based probes that target other enzymes, our 
approach may provide a viable tool for future high-throughput studies of enzyme-
associating proteins.  
 
2.4 Experimental details of the synthesis of the caspase probes 
3-Nitro-propionic acid tert-butyl ester (1) 
 A solution of 3-nitropropionic acid (2.38 g, 20 mmol) in dichloromethane was cooled to 
-50 C in an ice bath and concentrated sulfuric acid (0.08 ml, 1.50 mmol) was added. 
Isobutene gas was passed into the solution. After 48 h excess isobutene was removed by 










Actin, beta      
Proteasome activators complex subunit 4 
T-Cell receptor beta chain C region 
GTP-binding nuclear protein RAN 
Glyceraldehyde 3-phosphate dehydrogenase 
Fructose-biphosphate aldolase A 
Alpha enolase 



















degassing at the water pump pressure. The organic layer was washed with water (2 x 40 
ml), 5% NaHCO3 (2 x 40 ml), brine ((2 x 40 ml) and dried over sodium sulfate. The 
solvent was evaporated in vaccuo and the crude product was purified using flash column 
to furnish tert-butyl-3-nitropropionate as a yellow oil (2.52 g, 72%). 1H-NMR (300 MHz, 
CDCl3) δ 4.54-4.50 (t, J = 5.9 Hz, 2H); 2.82-2.78 (t, J = 6.3 HZ, 2H), 1.37 (s, 9H). 
 
5-Fluoro-4-hydroxy-3-nitro-pentanoic acid tert-butyl ester ( 2) 
To a cooled (-780 C) solution of oxalyl chloride (1.75 ml, 20.1 mmol) in 
dichloromethane, DMSO (2.86 ml, 40.3 mmol) was added slowly. The reaction mixture 
was stirred for 15 min. A solution of 2-fluoroethanol (1.00 g, 15.6 mmol) in 
dichloromethane (10 ml) was slowly introduced into the reaction flask. Another 15 min 
of stirring, the reaction mixture was diluted with anhydrous dichloromethane (150 ml) 
and triethylamine (10.9 ml, 78.2 mmol) was introduced to it. Stirring was continued for 
another 2 hrs at RT then a solution of 1 (2.73, 15.6 mmol) in dichloromethane (10 ml) 
was added to the reaction mixture and stirring was continued for overnight. The reaction 
mixture was then washed with water (2 x 40 ml), 4% HCl (3 x 40 ml), 5% NaHCO3 (2 x 
40 ml), brine ((2 x40 ml) and dried over Sodium sulfate. The organic layer was then 
separated and concentrated under reduced pressure and purified by flash column to 
afford, Tert-butyl-5-fluoro-4-hydroxy-3-nitropentanoate (2.65 g, 72 %). 1H-NMR (300 
MHz, CDCl3) δ 5.00 – 4.93 (m, 1H), 4.67-4.38 (m, 3H), 3.22-3.09 (m, 2H), 2.84-2.77 (m, 




3-Amino-5-fluoro-4-hydroxy-pentanoic acid tert-butyl ester (3) 
To 2 (2.65 g, 11.2 mmol) was added absolute ethanol (100 ml) and catalytic amount of 
freshly prepared Raney Nickel, the hydrogenation was carried at 2.5 bar for 24 h. After 
filtration and removal of the solvent at reduced pressure afford the crude product, which 
on purification with flash column furnished tert-butyl-amino-5-fluoro-4-hydroxy 
pentonoate ( 1.69 g, 73%). 1H-NMR (300 MHz, CDCl3) δ 4.61-4.38 (m, 2H), 3.77-3.58 
(m, 1H), 3.30 (m, 1H), 2.57-2.29 (m, 2H), 2.22 (m, 3H),  1.45(s, 9H). m/z 208.2 
[(M+1)]+. 
 
3-(3-Carboxy-propionylamino)-5-fluoro-4-hydroxy-pentanoic acid tert-butyl ester (4) 
A solution of succinic anhydride (0.50 g, 0.48 mmol) and DMAP (31 mg, 0.241 mmol) in 
DMF (5 ml) was added dropewise into a solution of compound 3, under nitrogen. The 
mixture was stirred overnight and evaporated under reduced pressure, the crude reaction 
mixture was taken in 20 ml of ethyl acetate and washed with 0.5 N HCl (2 x 10 ml) and 
brine (1 x 10 ml). The organic layer was separated and dried with sodium sulfate and 
concentrated to afford the product tert-butyl-3-(3-carboxy-propionlyamino)-5-fluoro-4-
hudroxy-pentanoate (0.14g, 95%)  as a yellow oil. 1H-NMR (300 MHz, CDCl3) δ 4.50-
4.19 (m, 3H), 3.97-3.88 (m, 1H), 2.70-2.42 (m, 6H), 1.4 (s, 9H). m/z 330.1 [(M+23)]+. 
 
3-[3-(2-tert-Butoxycarbonylamino-ethylcarbamoyl)-propionylamino]-5-fluoro-4-
hydroxy-pentanoic acid tert-butyl ester (5) 
To intermediate 4 (0.20 g, 0.65 mmol) in dichloromethane (5 ml) was added a solution of 
mono-tert-butoxycarbonylaminoethylamine (0.125 g, 0.78 mmol), EDC (0.15g, 0.781 
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mmol) and HOBt (0.13 g, 0.85 mmol) at 00 C. The reaction mixture was allowed to warm 
up to room temperature and allowed to stir overnight. Then the rection mixture was 
diluted with aqueous ammonium chloride (15 ml) and was extracted with 
dichloromethane (2 x 10 ml). The combined organic extracts were washed with brine and 
dried over sodium sulfate and concentrated  to give a crude mass which on further 
purification by flash coloumn afford the product (0.21 g, 72 %). 1H-NMR (300 MHz, 
CDCl3) δ 4.50-4.30 (m, 2H); 4.00-3.91 (m, 2H); 3.29 (br, t, 2H), 3.23 (br, t, 2H), 2.60-
2.45(m, 6H), 1.41(s, 18 H). m/z 450.1[(M+H)]+. 
 
3-[3-(2-tert-Butoxycarbonylamino-ethylcarbamoyl)-propionylamino]-5-fluoro-4-oxo-
pentanoic acid tert-butyl ester (6) 
Oxalyl chloride (0.065 ml, 0.75 mmol) in dichloromethane was added slowly to DMSO 
(0.11 ml, 1.5 mmol) under -780 C and stirred for 15 minutes after compound 5 (0.13 g, 
0.29 mmol) was slowly introduced into the flask. After another 15 minutes of stirring, 
triethylamine (0.41, 2.94 mmol) was added to it and stirred for another 1 h. Then the 
mixture was diluted with chloroform and washed with 4 % HCl (2 x 20 ml), water (1 x 20 
ml) and brine (1 x 20 ml). Drying of the organic phase and solvent evaporation furnished 
the crude material which on further purification by flash column gave the product as 
colorless oil (0.090 g, 70 %).  1H-NMR (300 MHz, CDCl3) δ 7.41 (br, d, J = 7.3 Hz, 1H), 
6.86 (br, s, 1H), 5.27-4.91 (m, 2H), 4.82 (br, q, 1H), 3.28-3.20 (m, 4H), 2.80-2.71(m, 




3-[3-(2-Amino-ethylcarbamoyl)-propionylamino]-5-fluoro-4-oxo-pentanoic acid (7)  
Compound 6 (0.020 g, 45 μmol) was dissolved in 50 % TFA in dichloromethane (2 ml) 
and stirred for an hour. The reaction mixture was evaporated to dryness and dried 
overnight to afford 7 (0.013 g, 99%). 1H-NMR (300 MHz, CDCl3) δ 5.34-5.00 (m, 1H), 
4.75 (br, s, 1H), 4.56-4.30 (m, 1H), 3.46 (br, t, 2H), 3.06 (br, t, 2H), 2.86-2.73 (m, 2H), 
2.58-2.50 (m, 4H). m/z 292.1 [(M-H)]-. 
 
Caspase-Cy3 probe (9) 
To 7 (0.21 g, 1mmol) was added  8 (0.54 g, 1 mmol) in DMF solution and stirred for 12 
hrs in the presence of 0.1 ml of DIEA at room temperature after which the reaction 
mixture was concentrated under reduced pressure and dissolved in 50 ml of ethyl acetate 
layer and washed with NaHCO3 ( 2 x 25 ml), water ( 2 x 25 ml) and brine (2 x 25 ml) to 
give a crude solid, which upon purification by reverse phase HPLC afford the probe 8 in 
43 % yield.  1H NMR (300 MHz, CDCl3 ) 8.40 (t, J=13.2 Hz, 1H); 7.45–7.36 (m, 4H); 
7.30–7.28 (m, 2H); 7.21–7.15 (m, 2H); 6.39 (2 unresolved d, 2H); 4.84 (br m, 1H); 4.66–
4.41 (m, 2H); 4.05 (br t, 2H); 3.63 (s, 3H); 3.38 (m, 4H); 2.90–2.87 (m, 2H); 2.57 (m, 
4H); 2.33 (br t, 2H); 1.80 (m, 4H); 1.73 (s, 12H) ppm; 13C NMR (75.4 MHz, CDCl3) 
203.1, 176.2, 174.3, 174.1, 173.4, 173.1, 172.7, 150.4, 142.4, 141.7, 140.3, 140.2, 129.0, 
128.9, 125.6, 125.5, 122.0, 121.9, 111.3, 110.9, 103.2, 103.1, 85.5, 83.1, 52.3, 49.2, 49.0, 
44.2, 39.5, 39.0, 35.3, 31.8, 31.3, 29.5, 28.0, 27.9, 26.6, 22.9 ppm; m/z calcd [(M+H)]+ 




1-(4-Carboxy-butyl)-2,3,3-trimethyl-3H-indolium; bromide (10) 
To bromrovaleric acid (3.50g, 19.3 mmol) was added 2,3,3-trimethyl-3H-indole (3.10ml, 
19.3mmol). The reaction was heated, with vigourous stirring, for 20 h at 1100 C. The 
burugundy solid was broken up and washed with hot ethyl acetate (6x40ml) and hot 
acetone (2 x 40ml and 2 x 120ml). Filtration of the solid and drying under vacuum 
afforded 3 as a pale pink powder. Yield : 3.06g (47%). 1H-NMR (300MHz, CD3OD + 
one drop D2O, 250C) 7.89-7.86 (m,1H); 7.79-7.76 (m,1H); 7.68-7.65 (m,2H); 4.57-4.52 
(t,2H); 2.46-2.41(t,2H); 2.06-1.96(m,2H); 1.81-1.71(m,2H); 1.61(s,6H)ppm; 13C-NMR 
(75.4MHz, CD3OD + one drop D2O, 250C) δ 198.0, 176.8, 143.4, 142.5,131.3, 
130.6,124.7,116.5, 56.0, 33.9, 28.2, 22.8 ppm; MS(ESI) cacld for C16H22N2O+ 260.16, 
found 260.0. 
 
2-[2-(Acetyl-phenyl-amino)-vinyl]-1,3,3-trimethyl-3H-indolium; iodide (11) 
To 1,2,3,3-tetramethyl-3H-indolium (2.0 g, 6.64 mmol), N, N’-diphenylforalmidine (1.64 
g, 8.36 mmol), and potassium acetate(71 mg, 0.72 mmol) was added in acetic anhydride 
(15ml). The mixture was heated for 5h at 1200C, during which time a red precipitate was 
formed. The reaction was cooled to room temperature and filtered to give an orange red 
powder. Yield: 2.04g (69%). 1H-NMR(300MHz, CDCl3, 250C) 9.21-9.16 (d, J = 14.5 Hz, 
1H); 7.74-7.68 (m,2H);7.66-7.62 (m,1H); 7.56-7.54 (m,2H); 7.50-7.45 (m, 4H) ; 5.64-
5.60 (d, J=14.5Hz, 1H); 3.86 (s,3H); 2.12 (s, 3H); 1.83 (s, 6H); 13 C-NMR (75.4MHz, 
CDCl3, 250C) 182.5, 170.3, 148.0, 141.9, 141.6, 135.6, 131.4, 130.4, 130.7, 129.4, 128.9, 
128.4, 122.3, 114.1, 97.9, 51.8, 35.3, 28.0, 23.5ppm, MS (ESI) calcd for C12H23N2O+ 
319.1810, found 319.0. 
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2-{3-[1-(4-Carboxy-butyl)-3,3-dimethyl-1,3-dihydro-indol-2-ylidene]-propenyl}-1,3,3-
trimethyl-3H-indolium; iodide, Cy3 (12) 
To 10 (0.50 g, 1.12 mmol), 9(0.40 g, 1.18 mmol) and potassium acetate (0.14 g, 1.43 
mmol) was added anhydrous 1- butanol (5 ml) under nitrogen. The mixture was heated 
with stirring for 1½ h at 1000C. Sodium Iodide (3.37 g, 22 mmol) was added to the flask 
and the reaction was heated for 1h at 1000C. The reaction was cooled to the room 
temperature and allowed to crystallize overnight. The crystals were washed with diethyl 
ether until the filterate was colorless. The product was dissolved in dochloromethane and 
concentrated in vacuo to red solid. The crude product was purified by column 
chromatography using a gradient solution of 30-50% ethanolic chloroform to give 6 as a 
red solid with a metallic green luster. Yield: 280mg (44%). 1H-NMR (300MHz, CDCl3, 
250C) tδ 8.39 (t, J=13.2 Hz, 1H); 7.34-7.41 (m, 4H); 7.27-7.21 (m, 2H); 7.13 (d, 
J=7.7Hz, 2H); 6.47 (t, J= 13.2 Hz, 2H); 4.10-4.06 (bt, 2H); 3.65 (s, 3H); 2.62-2.58 (bt, 
2H); 1.85 (s, 4H); 1.70 (s, 12H) ppm; 13C-NMR (75.4 MHz, CDCl3, 250C) δ 175.4, 
174.7, 173.8, 150.5, 142.5, 141.7, 140.5, 140.4, 129.0, 128.9, 125.6, 125.5, 122.2, 122.0, 
110.9, 103.9, 49.1, 43.7, 33.7, 31.3, 28.0, 26.2, 21.8 ppm; MS(ESI) calcd for 




indol-2-ylidene}-propenyl)-1,3,3-trimethyl-3H-indolium; iodide, Cy3-NHS (8) 
To a solution of 11 (4.43 g, 10 mmol) in DMF was added N-hydroxysuccinimide (1.4 g, 
12 mmol) and EDC (2.3 g, 12 mmol). The reaction was allowed to proceed overnight at 
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room temperature. The resulting mixture was dried in vacuo to remove DMF and purified 




4-(3, 6 - Diacetoxy-3H-xanthen-9-yl)-isophthalic acid, Fluorescein diacetate (14):  
Resorcinol (5.7 g, 52 mmol) was dissolved in 50 ml of CH3SO3H. To this solution, 
trimellitic anhydride (5 g, 26 mmol) was added, and the reaction was heated at 80-85 ºC 
for 12 hours. The highly viscous solution was cooled to RT then poured into 10 volumes 
of ice-cold water. The resulting precipitate was collected and dried in vacuo to give 
compound 13 as a crude yellow solid which was used without further purifications. This 
compound was then dissolved in 50 ml of acetic anhydride and 10 ml of pyridine. The 
solution was heated at 85 ºC for 15 minutes. The resulting solution was poured into ice-
cold water to give the crude precipitate of 14, which, upon recystallization with DCM, 
afforded pure 14 as white crystals (5.17 g, 53%). 
1
H-NMR (300 MHz, CDCl3) δ 8.75 (s, 
1H), 8.38 (d, J = 8.04 Hz, 1H), 7.29 (d, J = 8.04, 1H), 7.15-7.09 (m, 2H), 6.85-6.81 (m, 
4H), 2.31 (s, 6H). 
13
C-NMR (60 MHz, CDCl3) δ 168.71, 167.46, 165.85, 155.48, 152.12, 
150.69, 133.24, 132.47, 130.31, 129.23, 128.45, 126.14, 115.48, 110.41, 109.30, 81.21, 




Fluorescein diacetate-NHS (15):  
To a solution of FL-diacetate (4.6 g, 10 mmol) in DMF was added N-
hydroxysuccinimide (1.4 g, 12 mmol) and EDC (2.3 g, 12 mmol). The reaction was 
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allowed to proceed overnight at room temperature. The resulting mixture was dried in 




Caspase Fluorescein probe (16) 
To 7 (0.21 g, 1.0 mmol) was added fluorescein diacetate-NHS (15) (0.56 g, 1.0 mmol) in 
DMF solution and stirred for 12 h in the presence of 0.2 ml of pyridine. (NB: Since the 
fluorescein diacetate is labile in DIEA, its use was avoided). After which the reaction 
mixture was concentrated under reduced pressure and dissolved in 50 ml of ethyl acetate 
layer and washed with NaHCO3 ( 2 x 25 ml), water ( 2 x 25 ml) and brine ( 2 x 25 ml) to 
give the crude product which on further flash column purification afford 16 in 30 % 
yield. 1H-NMR (300 MHz, CDCl3) δ 8.47(m, 1H), 8.20 (m, 1H), 7.32 (m, 1H), 7.17 (s, 
2H), 6.87(m, 4 H), 4.82 (b, 3H), 3.56 (2H, m), 3.29 (2H, m), 2.73 (m, 1H), 2.56 (m, 4H), 
2.27 (s, 6H). m/z 734.1 [(M+H)] +. 
 
Biotin-NHS (17) 
To a solution of D-biotin (2.4 g, 10 mmol) in DMF was added N-hydroxysuccinimide 
(1.4 g, 12 mmol) and EDC (2.3 g, 12 mmol). The reaction was allowed to proceed 
overnight. The resulting mixture was dried in vacuo to remove DMF. The gel-like residue 
was recrystallized from EtOH/Acetic acid/H2O (95:1:4) to afford biotin-NHS as a white 
solid (2.9 g; 85% yield): 
1
H-NMR (300 MHz, CD3OD) δ 6.40 (br s, 1H), 6.35 (br s, 1H), 
4.33-4.29 (m, 1H), 4.17-4.13 (m, 1H), 3.12-3.08 (m, 1H), 2.86-2.81 (m, 5H) including 











342.1, found 342.1.  
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Caspase Biotin probe (18)  
To 7 (0.21 g, 1.0 mmol) was added  Biotin-NHS (0.341 g, 1.0 mmol) in DMF solution 
and stirred for 12 h in the presence of 0.1 ml of DIEA at room temperature after which 
the reaction mixture was concentrated under reduced pressure and dissolved in 50 ml of 
ethyl acetate layer and washed with NaHCO3 ( 2 x 25 ml), water ( 2 x 25 ml) and brine (2 
x 25 ml) to give a crude solid, which on purification by Reverse phase HPLC afford the 
probe 18 in 50 % yield. 1H-NMR (300 MHz, CDCl3) δ 4.91 (m, 2H), 4.82 (m, 1H), 4.37-
4.32 (m, 2H), 3.58 – 3.27 (broad, 6 H), 2.99 (m, 2H), 2.74 (m, 2H), 2.57 (m, 4H), 2.05 (t, 
2H), 1.59-1.29 (m, 6H); m/z 516.1 [(M-1)]-. 
 
Initial biochemical experiments using FMK-FL probe  
The Hela cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Sigma) 
containing 10% fetal calf serum (FCS, Gibco BRL), 100 units/ml Penicillin G and 100 
μg/ml Streptomycin Sulfate( Irvine Scientific, Santa Ana, CA) at 370C in a 5% CO2 
atmosphere. To induce apoptosis, HeLa cells were washed twice with phosphate-buffered 
saline (PBS), which was also added to the cell cultures during the time of UV irradiation.  
The cells were placed on a Hoefer™ MacroVue™ UV/Visible Transilluminator 
(Amersham, USA) at λ = 302 nm for 10 minutes. After UV exposure, fresh culture 
medium was added to the dishes. Uninduced, control cells were subjected to identical 
procedures but without UV exposure. Apoptosis of cells was examined by their 
morphology changes using fluorescence microscopy. To label the cells, probe FMK-FL 
was added to culture media (to a final concentration of 25 μM) 12 h after UVB 
irradiation. Labeling was carried for one and a half hour, and after which the cells washed 
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extensively with PBS buffer before imaging. To harvest the labeled cells, 0.2 mL of an 
ice-cold lysis buffer (PBS) was added to each of 150 mm dish of adherent HeLa cells. 
Cells were scraped off the dishes with a plastic cell scraper that has been cooled in ice-
cold distilled water. The cell suspension was transferred to a centrifuge tube. An equal 
volume of acid-washed glass beads (Sigma, 425-600 microns) was added, and the tube 
was placed in a mixer mill (Retsch, Haan, Germany) and lysed for 6 min at 40C. The 
supernatant liquid was collected by ultracentrifugation at 75 000 rpm for 1 h at 40C and 
subjected to SDS-PAGE/2D-GE and MS analysis. 
Note: Labeling experiments with FMK-biotin, streptavidin pull-down experiments, SDS-
PAGE/2D-GE and MS analysis etc were done exclusively by my colleague and hence the 











Chapter 3 Positional scanning peptide libraries of fluorogenic substrates 
to map the substrate specificity of proteases 
3.1 Introduction  
 
In the previous chapter, we have seen the specific targeting of a particular class of 
proteases using small molecule probes. It is evident that the design of these probes was 
made possible solely by the knowledge that caspases prefer Asp as P1 residue. The aim of 
the work done in this chapter is to gather such information on the substrate specificity of 
various classes of proteases which could eventually help in designing similar probes for 
other classes of proteases. Positional scanning peptide libraries are powerful tools for 
characterizing the substrate specificity of proteases at specific positions [71, 72]. 
However, these libraries must be coupled to an analytical assay capable of detecting and 
identifying the preferred substrates from a large excess of peptides. Incorporation of 
fluorescent-quenched molecules into either a support-bound or solution phase library 
enables detection of protease activity and simultaneous characterization of preferred 
sequences for sites both N- and C-terminal to the scissile bond [131- 134]. However, in 
most cases, the specific substrate and the actual site of cleavage are not immediately 
discerned by detection of fluorescence and therefore must be determined by subsequent 
analysis [132, 133]. In addition, the efficiency of fluorescent quenching and background 
fluorescence is related to the distance between the donor and quencher molecules, thus 
limiting the length of the substrate [131, 134, 135]. Another technique uses a PSL with a 
latent fluorophore at the site of cleavage [138-140]; the substrate preference is related to 
the intensity of fluorescence, and the sequence can be determined by the position in the 
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library. We chose to make use of this approach to obtain information on the substrate 
specificities at the important binding pockets of various classes of proteases by using a 
library of fluorogenic peptide substrates.  
Fluorogenic substrates that offer a spectrophotometric readout upon proteolysis 
are one of the most vital chemical tools for the characterization of proteases [141]. 
Previously fluorogenic molecules such as 7-amino-4-methyl coumarin (AMC) had been 
widely used for protease specificity assays [142]. AMC conjugated peptide substrate 
libraries have been employed to study the N-terminal specificity of proteases by sampling 
a wide range of substrates in a single experiment [143]. Specific cleavage of the anilide 
bond liberates the fluorogenic AMC leaving group, allowing for the simple determination 
of cleavage rates for individual substrates. Since amino acids with carboxyl side chain 
allows for the convenient synthesis of potential peptide substrate-AMC conjugates, most 
of these works were focused on describing the profiling of caspases. But since most other 
proteases does not need P1 aspartic acid or glutamic acid for enzyme activity, libraries 
made by these methods have narrow applicability. A more general approach has been 
developed which uses 7- amino-4- carbamoylmethyl coumarin (ACC) [144]. ACC can be 
directly attached to solid support through its carboxylic acid functional group enabling 
solid-phase peptide synthesis of peptide substrates, with P1 residue attached via its 
aromatic amine group. In addition to that, ACC has also shown 2.8-fold higher 
fluorescent yields than AMC, which allows more sensitive detection of protease activity. 
With this molecule, Ellman et al. constructed soluble positional protease substrate 
libraries and screened them against different proteases [139]. However, this approach 
does not allow determination of cooperative interactions between substrate residues 
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[145]. To fully profile the N-terminal substrate specificity of a protease, libraries of 
peptide-ACC conjugate must be immobilized onto the microarrays. In another report, the 
same group successfully generated a peptide array consisting of fluorogenic protease 
substrates via a chemoselective oxime linkage [146]. However, the oxime bond is not so 
stable. Independently our group developed a small molecule microarray capable of 
detecting activity of proteases and other hydrolytic enzymes with immobilized N-
hydroxysuccinimide (NHS)-activated ACC-peptide conjugate onto an amine-
functionalized glass slide [21]. But the restricted orientation of ACC ring was not that 
favorable to the optimum enzyme-substrate interaction.  
In the present chapter, we present an extension of our efforts to map the substrate 
specificity of various classes of proteases using ACC-peptide conjugates. A PS library 
containing potential protease substrate sequences has been synthesized and screened 
against proteases [29]. GG-K(Biotin) linker was attached to the C-terminus of each 
library for future microarray applications. The presence of this linker makes the library 
amenable to immobilization on avidin slides and also will allow optimum interaction 
between the protease and the peptide on the microarray. The synthesis of this library and 
their subsequent application in protease profiling will be discussed herein.  
3.2 Design of our fluorogenic peptide library 
A 60*18 member peptide library was synthesized and assayed against different classes of 
proteases. The ACC-peptide conjugates of the positional scanning library comprise of 
three sub-libraries each designed to scan the substrate preferences of proteases at 
primary, secondary and tertiary positions; P1, P2 and P3 respectively. Each sub library 
contains 20 different mixtures. 
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• XXP-ACC-G-G-Lysine (biotin)-CO-NH2   
• XPX-ACC-G-G-Lysine (biotin)-CO-NH2 
• PXX-ACC-G-G-Lysine (biotin)-CO-NH2 
P represents one of the 20 naturally occurring amino acids at defined positions 
and X represents randomized positions which constitute of an isokinetic mixture of all the 
18 amino acids. Cys and Met were avoided in the mixture in order to prevent side 
reactions via oxidation of their thiol groups resulting in the disulfide formation. The 
peptide substrates were conjugated with ACC through their P1 residue. Proteases would 
act to cleave certain substrate sequences preferentially, and upon release of the peptide, 
ACC is unmasked thus generating a strong fluorescence which may be quantitated. A 
protease fingerprint may thus be achieved by using a wide range of substrates. The 

























Fig. 19 (a) Schematic representation of the fingerprinting strategy (b) Amino-conjugated 
ACC substrates yielding free ACC upon enzymatic cleavage 
The excitation and emission maxima of the amino-conjugated ACC substrates are 
roughly around 325 nm and 400 nm, respectively. Proteolytic cleavage resulting in the 
generation of the free ACC results in a shift of the excitation and emission maxima to 350 
nm and 450 nm, respectively.  
3.3 Synthetic details of the ACC-library 
The key synthetic intermediates such as Fmoc Lysine (Biotin)-OH and Fmoc 
ACC were synthesized using the conventional solution phase synthetic methods. Biotin 
NHS (17) was coupled to the ε-amino group of Fmoc Lys (NH2)-OH to yield Fmoc 

































Scheme 5 Synthesis of K(Biotin) 
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Fmoc ACC was synthesized as per published protocols [139]. Starting from 
commercially available 3-aminophenol, treatment with ethyl chloroformate provides 
carbamate 20. Coumarin 21 was formed via a Pechmann reaction of carbamate 20 with 
1,3-acetonedicarboxylic acid in 70% H2SO4 in 63% yield after precipitation and 
crystallization from CH3CN. The carbamate 21 was hydrolyzed using 10 M NaOH with 
heating to reflux, and the resulting free amine 22 was protected with FmocCl utilizing the 
Meienhofer procedure [147] to provide the final product 23 (Scheme 6). A few cautions 
are crucial for the outcome of this reaction. It is important that the 1,3-
acetonedicarboxylic acid used in step 3 is pure. Heat triggers decarboxylation of 1,3-
acetonedicarboxylic acid, forming acetoacetic acid, which in turn leads to the formation 
of 7-carbethoxyamido-4-methylcoumarin (AMC) during the Pechmann reaction. This 
side product reduces the yield of the overall synthesis and also is difficult to be removed. 
For this reason, during the addition of 1.3 acetonedicarboxylic acid, temperature must be 
































Lys(Biotin) was loaded onto rink amide resin through its α-carboxylic acid by 
using standard coupling protocols in solvent NMP to yield resin bound intermediate 24. 
NMP was used since Lys(Biotin) was found to be more soluble in NMP than DMF. 
Resin-bound intermediate 26 was obtained by the subsequent loading of the dipeptide GG 
linker. Fmoc-ACC was loaded to the resin by an elongated coupling of 48 hours under 
HOBt/DIC/DMF conditions to give resin 27 (scheme 7). The use of DIEA was avoided 
in this step since the Fmoc group of ACC was found to be extremely labile under basic 









































(i) Fmoc-Gly-OH, HOBt, 
      DIC, DIEA, DMF, 6 h
(ii) 20% piperidine 
       in DMF, 1h
(iii) Repeat steps i-ii
20% piperidine 
     in DMF, 1h
Fmoc-ACC, EDC, 
HOBt, NMP, 48 h
20% piperidine 










































24 h Fmoc cleaves 
off 
 
Table 2 Optimization of conditions for ACC coupling  
 
Although the method B gives the highest loading in solution phase, problems 
were encountered with corresponding solid-phase ACC coupling. This was mainly due to 
the poor solubility of the free ACC in lesser amounts of solvents typically required for 
efficient solid phase coupling. On the other hand, Fmoc-ACC possesses good solubility 
in solvents DMF/NMP and hence the method D was chosen for solid phase coupling. The 
resin 27 was deprotected using 20% piperidine in DMF to yield resin 28. The completion 
of capping of the uncoupled resins was carried out using acetic anhydride/DIEA in 
dichloromethane. 
The peptide synthesis was performed using IRORI split-and-pool directed sorting 
technology [148] incorporating standard Fmoc-chemistry protocols. Synthesis is 
performed in Kan reactors. In each reaction step, all the micro reactors that share the 
synthesis of a common building block are pooled together into a single reaction flask. A 
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radio-frequency tag permits identification of each micro reactor at every step of a specific 
synthesis [149,150]. Micro reactors were added to the respective reagent solution and 
shaken at room temperature. Synthesis takes place as reagents flow through the outer 
mesh walls of the micro reactors while the resins remain captivated within the micro 
reactors. Synthesis Manager is the software that controls the directed sorting process in 
library synthesis. It records and assigns a code to each micro reactor in the first step and 
then in subsequent steps directs the sorting of the micro reactors to ensure the proper 
synthesis of all of the compounds. By tracking the unique tag ID, the identity of the 
compound can be obtained.  
The isokinetic mixture of 18 amino acids was generated using published protocols 
[66]. Owing to the poor nucleophilicity of the support bound aminocoumarin (due to the 
electron withdrawing effect of the phenyl ring), stronger coupling reagent like HATU in 
the presence of equimolar amount of the hindered organic base 2,4,6-collidine was used 
to obtain P1-substituted ACC-resin, 29 [139]. In most cases, double coupling was 
performed since a second coupling was proved to yield increased loading levels, 
especially for amino acids with comparatively lower coupling efficiencies. Subsequent 
couplings to load P2 and P3 residues were performed under standard coupling conditions. 
A 20% solution of piperidine in DMF was used for fmoc-deprotection throughout the 
synthesis. After each coupling/deprotection step, the resin was washed with solvents 
DMF, DCM and DMF in sequence. The peptides were cleaved from the resin using a 
mixture of TFA (95%), TIS (2.5%) and Water (2.5%), dissolved in DMSO to yield three 






















 XXP, XPX, PXX
(i) Coupling P or X
HATU, Collidine, DMF, 12h
(ii) 20% piperidine, DMF, 1h
(i) Coupling P or X
    HOBt, DIC, DIEA, DMF, 6h
(ii) 20% piperidine, DMF,1h
(i) Coupling P or X
    HOBt, DIC, DIEA, DMF, 6h







Scheme 8: Synthesis of the ACC conjugated positional scanning library 
3.4 Quality analysis of library  
Two definite sequences were synthesized as controls together with the PS library 
so as to analyze the quality of the library. K(biotin)GG-ACC-KPG-OAc and 
K(biotin)GG-ACC-RPG-OAc were used as the control peptides. We choose lysine as P1 
residue since these substrates could also be used in protease assays since many proteases 
like thrombin and trypsin prefer Lys and Arg residues at the P1 positions. The purity of 
the control sequences was determined by analytical RP-HPLC. 
 






0.00 10.00 20.00 30.00 40.00 50.00 
2487Channel 2 (254.00 nm)
K(biotin)GG-ACC-KPG-OAc 
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The major peak obtained at 254 nm was that of the desired peptide indicating the 
acceptable quality of our library. The minor peaks were corresponding to that of the 
unreacted and capped ACC chains.  
3.5 Fingerprinting experiments using ACC library 
Traditional microplate-based assays have been used for our and fingerprinting 
experiments [151]. Eleven different proteins were used to test against our ACC-peptide 
libraries; they include serine proteases (trypsin, α-chymotrypsin, β-chymotrypsin, 
subtilisin, thrombin and proteinase K), cysteine proteases (bromelain, chymopapain, 
ficin), achromopeptidase, as well as BSA which is not a protease (as a negative control). 
We found that, upon enzyme treatment, the fluorescence signal obtained for libraries 
containing the preferred amino acid residues were about 5-10 folds higher than the 
background fluorescence reading (e.g. before enzyme cleavage), which provided 
reasonably good signal-to-noise ratio. As shown in Fig. 20, the fingerprint profiles 
generated using the ACC PS library against enzymes tested in general agreed with 
previously reported literature, indicating the acceptable quality of our ACC library.  We 
also tested the libraries against BSA, a protein that does not possess any protease activity. 
As expected, no increase in fluorescence signal was observed from any of the 20 libraries 
after 1 h incubation. This confirms that increase in fluorescence observed is 
unambiguously due to the enzymatic cleavage of preferred ACC substrates by the 
proteases.  
3.6 Data analysis and conclusions 
The heatmaps shown in Fig. 20 was generated using the programs Tree View and 
Cluster written by Eisen and coworkers [152], which convert numerical values to a color 
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format. The proteases were arrayed along the x-axis, and the peptides along the y-axis 
(indicated by three-letter codes). Color in each grid indicates the relative fluorescence 
intensity generated by the protease upon treatment with a given peptide. As the absolute 
amount and activity of each commercial protease differs, the fluorescence profile of each 
protease was internally normalized, where “no fluorescence” was assigned as 0%, and 
“maximum fluorescence” as 100%.  
As shown in Fig. 20, in most cases the fingerprint profile of each protease 
correlated reasonably with the enzyme’s known substrate preference [153]. For example, 
thrombin, trypsin and bromelain are known to prefer basic residues such as Lys and Arg 
at the P1 position. Correspondingly they all showed high fluorescence signals towards 
ACC libraries having “Lys” and “Arg” residues at the P1 position. It is known that α-
chymotrypsin prefer hydrophobic residues such as glycine, valine and phenyl alanine at 
the P1 position. Correspondingly the enzyme showed high fluorescence signals towards 
the ACC libraries having valine and phenyl alanine residues at the P1 position. Enzymes 
like chymopapain having broad specificity showed fluorescence signals towards a 
number of peptide substrates in the library. 
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1               2            3             4           5              6            7          8            9            10 
 
Fig. 20 Fingerprint profiles of proteases obtained using ACC library 
List of enzymes (a): (1) Proteinase K (2) Achromopeptidase (3) Subtilisin (4) Bromelain (5) 
Chymopapain (6) β-Chymotrypsin (7) Ficin (8) α-Chymotrypsin (9) Thrombin (10) Trypsin  
In conclusion, our fingerprint experiments with coumarin-based fluorogenic 
positional scanning libraries have clearly shown that these libraries are well suited for 
mapping the substrate specificities of a wide range of proteases. These assays allow direct 

























3.7 ACC-azide library 
In this project, instead of the GG-biotin linker, α-azido lysine was used as a linker 
for future microarray applications. We synthesized a small library of ACC peptides 
consisted of six truncated fragments of TSAVLQ peptide sequence. The enzyme, SARS 
Coronavirus Main Protease 3CLpro has been reported to recognize TSAVLQ. Our library 
could potentially be used to study the minimum amino acid sequences required by the 
enzyme for effective substrate recognition. The sequences are Q-ACC-Lys(N3), LQ-
ACC-Lys(N3), VLQ-ACC-Lys(N3), AVLQ-ACC-Lys(N3), SAVLQ-ACC-Lys(N3) and 
TSAVLQ-ACC-Lys(N3). The azide group facilitates immobilization of peptides onto 
alkyne functionalized glass slide through a 1, 3-dipolar cycloaddition which is a high-
yielding, rapid, and site specific reaction [154]. 
 
3.8 Chemical synthesis of the azido-ACC-peptides 
 
Freshly prepared TfN3 was used to convert amino group in side chain of Fmoc 
protected lysine to azide 33 [155]. Compound 33 was then be loaded onto Rink amide 
resin using DIC /HOBt/DIEA coupling chemistry to yield resin 34. After Fmoc 
deprotection using 20% piperidine/DMF, Fmoc-ACC was coupled to the resin as 
described in the section 3.3 to obtain resin 35.  Fmoc group was deprotected and the free 
amino group of the ACC was acylated with Fmoc protected amino acids using 
HATU/Collidine coupling protocols to load P1. Subsequent couplings were done using 
standard coupling protocols to obtain the required peptide sequence. Completions of the 
reactions were followed by ninhydrin test. The peptides were cleaved from the solid 
support using trifluoroacetic acid to yield the azido-ACC-peptide substrates (38 and its 
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DIC, HOBt, DIEA
DMF, 12h
 (i) 20% piperidine, DMF
(ii) ACC,DIC,HOBt, DMF
(i) Fmoc -AA-OH,HOBt, 
     DIC, DIEA, 6h


































Scheme 9 Synthesis of azido-ACC conjugates  
 
 
3.9 Experimental details Synthesis 
3.9.1 Experimental details of syntheses of ACC-Positional scanning library 
Fmoc-Lys (Biotin)-OH (19). 
Biotin-NHS was prepared as described in Chapter 2. 
 73
To a solution of Fmoc-Lys(Boc)-OH (39.8 g, 85 mmol) in DCM (80 ml) was added TFA 
(80 ml). The reaction was stirred at room temperature for 1 hour and concentrated in 
vacuo. The oil residue was dissolved in 280 ml of 1:1 Dioxane/water co-solvent, and the 
pH of the solution was adjusted to 8~8.5 by using a 4 M NaOH solution at 00C. Biotin-
NHS, 17 (29 g, 85 mmol) and was subsequently added, and the reaction mixture was 
stirred at room temperature overnight. The resulting gelatinous solid formed was added 
ether, stirred for 5 minutes. The supernatant ether was decanted followed by addition of 
acetone and adjusting the resulting solution to pH 3 using 2 M HCl at 00C. Finally, the 
solid was filtered, washed several times with MeOH to afford the pure Fmoc-K(Biotin)-
OH as a white solid (41.5 g, 82%): 
1
H-NMR (300 MHz, CD3OD) δ 7.88 (d, J = 7.5 Hz, 
2H), 7.71 (d, J = 7.7 Hz, 2H), 7.40 (t, J = 7.2 Hz, 2H), 7.32 (t, J = 7.3 Hz, 2H), 6.42 (br s, 
1H), 6.34 (br s, 1H), 4.31-4.22 (m, 4H), 4.12-4.08 (m, 1H), 3.91-3.84 (m, 1H), 3.10.-3.00 
(m, 3H), 2.80 (dd, J = 4.9 Hz, J = 12.2 Hz, 1H), 2.56 (d, J = 12.5 Hz, 1H), 2.03 (t, J = 7.3 






To a 2 L round-bottom flask fitted with a stir bar were added 3-aminophenol (150 g, 1.37 
mol) and EtOAc (500 mL). The flask was fitted with a condenser, and the mixture was 
heated to reflux for 30 min. Ethyl chloroformate (74.6 g, 0.687 mol) was added dropwise 
over a 1 h period. The reaction mixture was allowed to cool to room temperature at which 
time a white precipitate formed. The precipitate was removed by filtration and washed 
with EtOAc (3 × 300 mL) and petroleum ether (3 × 300 mL). The combined filtrate was 
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concentrated to afford 123 g (99%) of 20 as a white solid. The product was sufficiently 
pure by NMR analysis to be taken on to the next step without further purification. 1H 
NMR (300 MHz, CDCl3) δ 10.11(brs, 1H), 7.55 (t, J = 8.0 Hz, 1 H), 7.38 (d, J=8.0 Hz, 
1H), 6.30 (s, 1 H), 4.17 (q, J=7.1 Hz, 2H), 1.25(t, J=7.0 Hz, 3H). ESI mass spectrum: 
m/z 182.0 (M+1)+. 
 
7-N-(Carbethoxy)aminocoumarin-4-acetic Acid (21). 
To a 5 L round-bottom flask fitted with a stir bar were added 20 (100 g, 0.552 mol) and 
70% H2SO4 (2.75 L). The rapidly stirred reaction mixture was cooled in an ice bath, and 
1,3-acetonedicarboxylic acid (88.7 g, 0.607 mol) was added in portions. The reaction 
mixture was allowed to warm to room temperature and stirred for 8 h, after which the 
reaction mixture was poured onto ice (4 kg) and stirred for 30 min. The resultant white 
precipitate was collected by filtration and washed with Et2O (3 × 2 L). The crude material 
was then partially dissolved in hot CH3CN (700 mL). Upon cooling to room temperature, 
the precipitate was collected to afford 101 g (63%) of 21 as a white solid. mp 194-1950C. 
1H NMR (300 MHz, CDCl3) δ 9.43(brs, 1H), 7.0 (m, 2H), 6.85 (m, 1H), 6.37 (m, 1 H), 
4.08 (q, J=7.1 Hz, 2H), 3.44(brs, 1H), 1.22(t, J=7.0 Hz, 3H). ESI mass spectrum: m/z 
292.1 (M+1) 
 
7-Aminocoumarin-4-acetic Acid (22).  
To a 2 L round-bottom flask fitted with a condenser were added 21 (101 g, 0.345 mol), 
NaHCO3 (138 g, 3.45 mol), and H2O (900 mL). The reaction mixture was stirred at reflux 
for 16 h. After cooling to room temperature, the pH of the reaction mixture was adjusted 
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to 2, by the dropwise addition of H2SO4. The resultant yellow precipitate that formed was 
collected by filtration to afford 64.3 g (85%) of 22 as a fluffy yellow powder. The 
product was sufficiently pure by NMR analysis to be taken on to the next step without 
further purification. 1H NMR (300 MHz, DMSO) δ 7.36 (d, J = 8.7 Hz, 1 H), 6.56 (dd, J 
= 8.7, 1.7 Hz, 1 H), 6.42 (d, J = 1.7 Hz, 1 H), 6.13 (brs, 2 H), 5.96 (s, 1 H), 2.50 (s, 2 H). 
ESI mass spectrum: m/z 220.2(M+1) 
7-Fmoc-aminocoumarin-4-acetic acid, 23.  
7-Aminocoumarin-4-acetic acid, 22 (10.0 g, 45.6 mmol) and H2O (228 ml) were mixed. 
NaHCO3 (3.92 g, 45.6 mmol) was added in small portions followed by the addition of 
acetone (228 ml). The solution was cooled with an ice bath, and Fmoc-Cl (10.7 g, 41.5 
mmol) was added with stirring over the course of 1 h. The ice bath was removed and the 
solution was stirred overnight. The acetone was removed with rotary evaporation and the 
resulting gummy solid was collected by filtration and washed with several portions of 
hexane. The material was dried over P2O5 to give 14.6 g (80%) of cream-colored solid. 1H 
NMR (300 MHz, DMSO) δ 10.19 (brs, 1H), 7.37-7.89 (m, 11 H), 6.33 (s, 1H), 4.55 (brs, 
2H), 4.33(s, 1H), 3.85 (brs, 2H)). 13C NMR (101 MHz): 37.9, 47.4, 66.8, 67.2, 105.5, 
114.6, 115.3, 121.1, 125.9, 126.9, 128.0, 128.6, 141.6, 143.6, 144.5, 150.7, 154.1, 154.8, 
160.8, 171.4. ESI mass spectrum: m/z 442 (M-1)-. The HPLC profile of the final product 
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HPLC conditions:  20 to 100% CH3CN in 15 min then to 100% CH3CN in 3 min  
 
Fmoc-Lys (biotin)-OH resin (25)  
To a 1-litre glass bottle was added a solution of 20% piperidine in NMP and 12 g 
of Rink Amide AM resin (loading: 0.7 mmol/g). The mixture was shaken for 2 hours. 
The resin was filtered and washed with DMF (3 x), DCM (3 x) and DMF (3 x). Fmoc-
Lys (biotin)-OH (4.0 eq), HOBt (4.0 eq) and DIC (4.0 eq) were dissolved in minimal 
amount of DMF and added to the resin. DIEA (8.0 eq) was added and the reaction 
mixture was agitated overnight at room temperature. The resin 24 was then washed with 
DMF (3 x), DCM (3 x) and DMF (3 x). Ninhydrin test was carried out to check for the 
completion of coupling. Subsequently, Fmoc group was cleaved by treating the resin 24 
with a solution of 20% piperidine in DMF for one hour. The resin 25 was filtered and 
washed with DMF (3 x), DCM (3 x) and DMF (3 x) and dried in vacuum.  
 
Loading of GG linker 
Fmoc-Gly-OH (4.0 eq), HOBt (4.0 eq), HBTU (4.0 eq) and were dissolved in 
minimal amount of DMF. DIEA (8.0 eq) was added to the reaction mixture and the 
reaction mixture was agitated for 10 min. The preactivated solution was then added to the 
Fmoc-ACC Fmoc-AMC 
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resin and the reaction was allowed to proceed for 6 hours. The resin was collected by 
filtration and washed with DMF (3 x), DCM (3 x) and DMF (3 x). Fmoc was cleaved by 
treating the resin with a solution of 20% piperidine in DMF for one hour and the resin 
was washed with DMF (3 x), DCM (3 x) and DMF (3 x). The coupling and deprotection 
procedures were repeated to load the second Fmoc-Gly-OH to yield resin 26.  
Loading of ACC  
A solution of Fmoc ACC (6eq), HOBt (6eq) and DIC (6eq) in minimal amount of 
NMP was added to the resin 26 and the reaction mixture was agitated for 48 hours at 
room temperature. The resin 27 was collected by filtration and washed with DMF (3 x), 
DCM (3 x) and DMF (3 x). About 10 mg of the resin was cleaved using neat TFA and 
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Condition: 20 to 100% CH3CN in 30 min then to 100% CH3CN in 10 min  
The resin was deprotected by 20% piperidine in DMF for one hour and washed as 
described above, to yield resin 28. About 30 mg of the resin 28 was weighed and added 
into each microreactor along with the radio-frequency tags. The microraectors were then 
divided into three sets (of 20 reactors each) for the synthesis of and XXP, XPX, PXX 
sub-libraries. Ninhydrin test was carried out after each coupling step to check for the 
completion of reaction through out the library synthesis.  
K(biotin)GG-ACC-Fmoc 
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 XXP sub library  
The 20 microreactors were distributed into twenty bottles and each bottle was 
subjected to a solution of a unique Fmoc-protected amino acid (5.0 eq), HATU (5.0 eq) 
and 2, 4, 6 Collidine (5.0 eq) in DMF (2.5 ml). After agitating for 12 h, the microreactors 
were filtered, pooled together and washed with (3 x 100 ml), DCM (3 x 100 ml) and 
DMF (3 x 100 ml). The procedure was repeated for double coupling. The Fmoc group 
was deprotected by 20% piperidine and the microreactors were filtered and washed as 
described above. A solution X, an isokinetic mixture of 18 amino acids (4.0 eq), HOBt 
(4.0 eq), DIC (4.0 eq), DIEA (4.0 eq) in DMF (50 ml) was added. The reaction was 
allowed to proceed for 6 hours at room temperature. The microreactors were filtered, 
pooled together and washed as described above. Subsequently, Fmoc was removed by 
treating the resin with a solution of 20% piperidine in DMF. The procedure for coupling 
X was repeated to load the P3 residue. 
XPX sub library 
The second set of 20 microreactors were pooled into one bottle and added a 
solution of X, an isokinetic mixture of 18 amino acids (5.0 eq), HATU (5.0 eq) and 2, 4, 
6 Collidine (5.0 eq) in DMF (50 ml) and shaken for 12 hours. The microreactors were 
then filtered and washed as described above. The procedure was repeated for double 
coupling. The Fmoc group was then deprotected and the 20 microreactors were 
distributed into twenty bottles and each bottle was subjected to a solution of a unique 
Fmoc-protected amino acid (4.0 eq), HOBt (4.0 eq), DIC (4.0 eq), DIEA (4.0 eq) in DMF 
(2 ml). The reaction was shaken for 6 hours at room temperature. After washing, the 
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Fmoc group was removed and the procedure for coupling P2 residue was repeated using a 
solution of X (instead of the unique amino acids) to load the P3 residue. 
PXX sub library 
The P1 residue is loaded as in the PXX library synthesis. The second residue was 
coupled under X (4.0 eq), HOBt (4.0 eq), DIC (4.0 eq), DIEA (4.0 eq) in DMF (50 ml) 
conditions. The reactors were filtered and washed with DMF (3 x), DCM (3 x) and DMF 
(3 x). The Fmoc group was removed and the 20 microreactors were distributed into 
twenty bottles and each bottle was subjected to a solution of a unique Fmoc-protected 
amino acid to load the P3 residue. 
Acylation of the N-terminal of peptides 
At the end of the library synthesis the reactors were pooled together and treated 
with acetic anhydride (10eq) and DIEA (20eq) in DCM the agitated for 1h.  
Cleavage from the solid support  
The peptide library was sorted into a 96-well cleavage station (Irori) and cleaved 
from the resin with a TFA cleavage solution (1.5 ml TFA (95%), TIS (2.5%) and Water 
(2.5%) in each well) and the mixture was shaken for 2 hours at room temperature. The 
cleavage solution was then transferred to 96-well plates and then concentrated in vacuum. 
The product in each well was diluted with EtOH (0.5 ml) and concentrated twice to 
remove the traces of TFA. The contents of the individual wells were lyophilized from 
CH3CN/ H2O mixtures. Then each peptide was dissolved in DMSO (1 ml). 
Procedure of Kaiser’s test 
The following reagents were prepared: 
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Reagent A: 5 g ninhydrin in 100 ml ethanol 
Reagent B: 0.3 g phenol in 0.6 ml pyridine and 0.1 ml ethanol. 
The resin beads were washed several times with ethanol and transferred to a small test 
tube.  7 drops of reagent A and 3 drops of reagent B were added. The mixture was heated 
to 1200C for ~2 minutes. Blue resin beads indicate the presence of free amine groups on 
resin. MBHA resin was used as positive control. 
 
General procedure for enzyme assay  
Substrates from the positional scanning combinatorial libraries were dissolved in 
1.0 ml DMSO and stored at -600C. All peptide stock solutions were normalized to a 
uniform concentration by UV measurements of ACC absorbance from each peptide 
library. The peptide libraries were diluted (by 100 folds) into a Tris Buffer (50 mM, pH = 
8) before enzyme assays. Stock solutions from commercial enzymes were prepared to ~1 
mg/ml in 50 mM Tris buffer (pH 8). The protease assays were carried out in black round-
bottom polypropylene 96-well microtitre plates (Nunc, USA). Briefly, 1 μl of each 
peptide library was added into the well of the microplate already filled with 98 μl of Tris 
buffer (pH = 8). After thorough mixing by gentle shaking, the background fluorescence 
reading of each well was recorded on a SpectraMAX™ Gemini XS fluorescence plate 
reader (Molecular Devices, USA) at λex = 355 nm and λem = 460 nm. Subsequently, 1 μl of 
each enzyme stock solution was added to the solution, giving the final enzyme 
concentration of 1 μg/ml in each assay. For enzymes from the cysteine protease class, 5 
mM of DTT (final assay concentration) was added to the assay in order to ensure the 
enzymes were active. The fluorescence intensity was continuously monitored at room 
temperature for one hour at λex = 355 nm and λem = 460 nm.  
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3.9.2 Experimental details of syntheses of azido-ACC peptides 
α-Azido-ε-N-Fmoc-lysine (33) 
A solution of sodium azide (1.78 g, 27.45 mmol) was dissolved in distilled water (4.5 ml) 
with CH2Cl2 and cooled on an ice bath to 50C. Triflyl anhydride (0.93 ml, 5.55 mmol) 
was added slowly over 5 minutes and the reaction mixture was allowed to warm up to 
room temperature. After 2h, the aqueous and organic layers were separated and the 
aqueous layer was extracted with CH2Cl2 (2 x 3.75 mL). The combined organic fractions 
were washed once with saturated Na2CO3 and used without further purification.  
Fmoc-Lys(Boc)-OH (3.8 g, 8.1 mmol) was dissolved in 1:1 mixture of TFA/CH2Cl2 (12 
mL). The mixture was stirred for 1 hour and the solvent was removed by evaporation to 
afford a white solid (2.97 g, 99% yield). To this solid (1.0 g, 2.79 mmol) added a solution 
of K2CO3 (577 mg, 4.19 mmol) and CuSO4. 5H2O (6.98 mg, 27.9μmol) in distilled H2O/ 
CH3OH (9 mL/18 mL). 6 in CH2Cl2 (15 mL) was added and the mixture was stirred at 
ambient temperature for 12 hours. The organic solvent was removed under reduced 
pressure and the aqueous slurry was diluted with H2O (50 mL). This was acidified to pH 
3 with diluted HCl and extracted with EtOAc (4 x 20 mL). The EtOAc extracts were 
combined, dried with MgSO4 and evaporated to dryness. Further purification by flash 
column chromatography (5% CH3OH in CH2Cl2) afforded 7 as white powder (0.94 g, 
85.7%). 1H NMR (300 MHz, CD3OD), δ 7.77 (d, J= 7.62 Hz, 2H), 7.63 (m, 2H), 7.28-






Rink amide resin was deprotected with 20% piperidine for 1 hour. The resin was filtered 
and washed with DMF (3 x), DCM (3 x) and DMF (3 x). Compound 7 (4.0 eq), HOBt 
(4.0 eq) and DIC (4.0 eq) were dissolved in minimal amount of DMF and added to the 
resin. DIEA (8.0 eq) was added and the reaction mixture was agitated overnight at room 
temperature. The resin was then washed with DMF (3 x), DCM (3 x) and DMF (3 x). 
Ninhydrin test was carried out to check for the completion of coupling. Subsequently, 
fmoc group was cleaved by treating the resin with a solution of 20% piperidine in DMF 
for one hour. The resin was filtered and washed with DMF (3 x), DCM (3 x) and DMF (3 
x) and dried in vacuum. Fmoc-ACC was coupled to the resin as described in section 
3.9.1. Fmoc-Gln(Trt)-OH (4 eq), HATU(4eq), and collidine (4eq) was dissolved in 
minimal amount of DMF and agitated for 30 min. The solution was then added to the 
resin and agitation was continued for 20 hours. The resin was then filtered, washed with 
DMF (3 x), DCM (3 x) and DMF (3 x) and dried in vacuum. The fmoc group was 
removed and described above. Fmoc-Leu-OH (4.0 eq), HOBt (4.0 eq) and DIC (4.0 eq) 
were dissolved in minimal amount of DMF and added to the resin. DIEA (8.0 eq) was 
added and the reaction mixture was agitated overnight at room temperature. The resin 
was then filtered, washed with DMF (3 x), DCM (3 x) and DMF (3 x) and dried in 
vacuum. The coupling and deprotection procedures were repeated to attach the 
subsequent amino acids to obtain the desired peptide sequence. The resin was cleaved by 
agitation for 1 h in a solution of TFA: H2O: TIS (95:2.5:2.5). The solution was then 
removed under reduced pressure and the crude peptide was dissolved EtOH (0.5 ml) and 
concentrated twice to remove the traces of TFA.  
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Aliquots of the resin (100 mg) were taken out after each coupling step and cleaved to get 
the truncated peptides. All the peptides were purified by RP-HPLC and characterized by 
ESI-MS (Table 3)  


















Chapter 4 Fingerprinting of metalloproteases and cysteine proteases 
using positional scanning peptide libraries  
The aim of the project presented in this chapter is to study the substrate/binding 
specicity profiles of metalloproteases and cysteine proteases. As described in chapter 3, 
here also we rely on positional scanning peptide libraries for the studies of the substrate 
specificity or “fingerprinting” of these proteases.   
4.1 Affinity based fingerprinting of metalloproteases using a positional scanning 
inhibitor library of peptidyl hydroxamates 
Metalloproteases are a class of hydrolytic enzymes belonging to the protease 
family. Metalloproteases, such as the matrix metalloproteinases (MMPs) and angiotensin 
converting enzymes (ACE) [156, 157] have been shown to actively participate in a 
number of physiological pathways such as tissue modeling and blood pressure regulation, 
rendering them potential pharmaceutical targets for diseases such as arthritis [158], 
Alzheimer’s disease [159], cancer [160] and heart disease [161]. These enzymes, through 
a catalytic zinc(II) ion coordinated to three amino acid residues (usually His and Glu) and 
a water molecule located within the enzyme active site, hydrolyze peptide bonds via a 
general-base mechanism. During the hydrolysis, the tetrahedral peptide intermediate 
formed is coordinated to zinc but not covalently bound to the enzyme [162, 163]. 
Consequently, no mechanism-based, irreversible inhibitors of these enzymes are 
currently known, making it impossible, using existing strategies to develop suitable 
chemical probes for activity-based profiling experiments. The denaturing aspect of 
current activity-based protein profiling strategies limits the classes of chemical probes to 
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those which irreversibly and covalently modify their targeting enzymes. Our group 
recently developed an affinity-based labeling approach to profile enzymes which do not 
possess covalently bound substrate intermediates [22]. The design template of affinity-
based probes targeting metalloproteases consists of a peptidyl hydroxamate zinc-binding 
group (ZBG), a fluorescent reporter tag, and a photolabile diazirine group.  Photolysis of 
the photolabile unit in the probe effectively generates a covalent, irreversible linkage 
between the probe and the target enzyme, rendering the enzyme distinguishable from 
unlabeled proteins upon separation on a SDS-PAGE gel. Since one of the prerequisites 
for our labeling strategy is the presence of a functionally active site in the enzyme for the 
probe to bind before photo-labeling can occur, the extent of the enzyme labeling by a 
given probe can therefore be used to indirectly reflect the relative enzymatic activity of 
the enzyme, as well as the relative affinity of the probe against the enzyme, or both. 
Previously, Cravatt et al. had showed that activity-based profiling approaches 
were suitable for in situ screening of potential enzyme inhibitors [164].  In this project, 
we made an attempt to find out whether our affinity-based approach could be used to 
screen for potential metalloprotease inhibitors. We chose to label thermolysin by 
photoaffinity probe (general structure of the probe is as shown in Fig. 21b, for our 
experiments, P1 = Leu) in the presence of positional-scanning inhibitor libraries and 
studied the activity of these inhibitors against thermolysin. A positional-scanning library 
of peptidyl hydroxamates having Leu at the P1 position was synthesized. The library was 
used to investigate the substrate specificity of metalloproteases at the P2-P4 positions. An 
array of eight representative amino acids was selected to individually “scan” through the 
P2-P4 positions in each library. With increasing concentrations of the inhibitor in the 
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reaction, concurrent decreases in the fluorescence intensity of the thermolysin labeling by 
the affinity probe was observed. All the inhibitors from the positional scanning library 
showed a good inhibitory activity against thermolysin, with more potent inhibitors 
consistently possessing hydrophobic residues at P2-P4 positions (i.e., Pro and Leu). 
(a)  
        
P2 to P4 
1 = Ala 
2 = Glu 
3 = Phe 
4 = Lys 
5 = Leu 
6 = Pro 
7 = Gln 
8 = Ser 



















        
Fig. 21 (a) MMP inhibitor library (b) The photoaffinity probe used for labeling  
 
4.1.1 Synthesis of the peptidyl hydroxamate library 
 
Library collections were represented by sequences XXPL-NHOH, XPXL-NHOH 
and PXXL-NHOH. Leucine, the residue preferred by thermolysin at the P1′ position, was 
unaltered in the inhibitor libraries and a tripeptide CGG was used as a linker at the C-
terminus of all peptides. P represents defined positions of eight representative amino 
XX1L X1XL 1XXL 
XX2L X2XL 2XXL 
XX3L X3XL 3XXL 
XX4L X4XL 4XXL 
XX5L X5XL 5XXL 
XX6L X6XL 6XXL 
XX7L X7XL 7XXL 
XX8L X8XL 8XXL 
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acids Ala, Glu, Phe, Lys, Leu, Pro, Gln and Ser chosen to be individually “scanned” from 
P2 through P4 positions, so as to identify the preferred residues at each position. Isokinetic 
mixture [66] of 18 amino acids (20 standard amino acids, minus Cys and Tyr) was used 
in position X. Hydroxylamine hydrochloride was protected at the amino position using 
Fmoc-Cl in presence of sodium bicarbonate to afford Fmoc-NHOH (39). Hydroxamate-
functionalized resin (40) was prepared from 2-chlorotrityl resin and Fmoc-NHOH as 
previously reported [165]. Subsequent peptide coupling steps were carried out in a 96-
well block reactor system (FlexChem, USA) using HBTU-mediated Fmoc peptide 
coupling protocols [20] resulting in a total of 24 peptide hydroxamate libraries (45). Two 
control peptides were synthesized together with the PS library, CGGGGL as positive 



































 (ii) 20% piperidine
   in DMF, 30 min
(i) Fmoc-NH-Leu-OH
TBTU, HOBt, DIEA
 (ii) 20% piperidine
   in DMF, 30 min
(i) Coupling with P or X
HBTU, HOBt, DIEA
 (ii) 20% piperidine
   in DMF, 30 min
(i) Coupling with P or X
HBTU, HOBt, DIEA
 (ii) 20% piperidine
   in DMF, 30 min











Scheme 10 Synthetic route for the peptidyl hydroxamate library 
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4.1.2 Gel-based inhibition experiments using the peptidyl hydroxamate library 
Dose-dependent inhibition experiments were carried out where the thermolysin labeling 
reaction with photoaffinity probe was performed in the presence of different 
concentrations of each member from the positional scanning library, and the extent of 
labeling was compared and internally calibrated with control experiments in which no 
inhibitors were added (Fig. 22a). Results were summarized, in which IC50 values of each 
PS member were compared (Fig. 2b): all 24 hydroxamates showed a good inhibitory 
activity against thermolysin, with more potent inhibitors consistently possessing 
hydrophobic residues at P2-P4 positions (i.e., Pro and Leu).  
If one assumes the PS peptides bind inversely to the active site of thermolysin like 
other hydroxamate-based inhibitors [166] (e.g., Z-GGL-NHOH), our results thus agree 
well with previous reports that thermolysin prefers hydrophobic amino acids at their P2′-
P4′ positions.  Putting together these results indicates that the affinity-based labeling 














Fig. 22 (a) Images of the gel-based inhibition experiments with representative members of the 
PS library (b) Plot of IC50 values from dose-dependent inhibition experiments of thermolysin 
labeling by affinity probe in the presence of varying concentrations of peptides from the 
positional scanning library 
4.2 Activity based fingerprinting of cysteine proteases using a positional scanning 
library of peptide vinyl sulfone probes 
Cysteine proteases are distinguished by the thiol chemistry of the catalytic 
cysteine residue in the active site with important physiological implications in a number 
of disease conditions. The structural differences among the cysteine proteases have found 
useful in the design of specific inhibitors or probes. Positional scanning libraries have 
been used previously to profile cysteine proteases. For example, Bogyo et al. have 
synthesized peptide epoxide libraries and studied their specificities toward cysteine 
proteases at the P2 position [52]. Thus far a significant number of irreversible mechanism 
based inhibitors have been developed for cysteine proteases. Containing a double bond 
activated by an electron withdrawing sulfonyl group, the vinyl sulfones act as 
electrophilic traps irreversibly inactivating the catalytic cysteine residue within the active 
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site of the enzyme [15, 167]. As the β-carbon of the vinyl sulfone is soft in nature, it is 
activated only towards the soft thiolate of the cysteine proteases and not the hard 
oxyanion of serine proteases. In addition, the greater versatility in the design of the 
reactive unit can be achieved by the possibility of manipulating both the P and P’ side 
chains. It is well-known that, for many cysteine proteases, e.g. caspases, the most critical 
component in a protease substrate is the P
1 
residue. We envisaged that, by varying the P
1 
residue in our probes with a variety of diverse functional groups and generating a panel 
of cysteine protease-specific, activity-based probes, one may use them to obtain quick 
substrate fingerprint profiles of these enzymes. Moreover, efficient solid-phase strategies 
which allows convenient synthesis of peptide vinyl sulfones bearing different P and P
’ 
substitutions have already been developed in our lab [26, 27]. The present chapter deals 
with an extension of these efforts: using a positional scanning library of vinyl sulfone 
probes with P1 variation, affinity data for the S1 binding pocket of various cysteine 
proteases were obtained. Synthesis of these probes was done together with a fellow 
colleague. 
 
Fig. 23 Mechanism of peptide vinyl sulfone inhibiting cysteine proteases 
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Each peptide vinyl sulfone used in our study contains three units - a recognition unit 
consisting of any of 20 different amino acids (18 natural aminoacids except Cys and Met 
and 2 unnatural aminoacids Orn and D-Phe) mimicking the P
1 
position of a protease 
substrate followed by a common Leu-Leu dipeptide linker, a vinyl sulfone moiety serving 
as the warhead for covalent reaction with the enzyme (via its active-site Cys residue), and 
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Fig. 24 Positional scanning library of peptide vinyl sulfones 
4.2.1 Synthesis of the vinyl sulfone library 
Synthesis of the probes was performed using the procedures developed in our lab 
previously [27]. Starting from commercially available 4-mercapto-benzoic acid, sulfide 
phosphonate 48 was prepared through the nucleophilic reaction with diethyl iodomethyl 
phosphonate in the presence of DBU. Compound 48 was conveniently loaded onto the 
rink amide resin using the standard DIC/HOBT/DIEA coupling procedures to afford the 
resin-bound sulfide phosphonate 49. Oxidation of resin 49 was accomplished by 
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46 (a-t) 47 (a-t)
Diethyl iodomethyl 
phosphonate
DBU, DMF, 6 h , 77%
Rink amide Resin, DIC
HOBt, DIEA, DMF, 6h
m-CPBA, 
DCM, 1 h
    LHMDS,
    Fmoc-AA-H ,THF
(i) DBU/HOBt, DMF,
     10 min
(ii) Fmoc-Leu-OH, DIC
       HOBt, DIEA, DMF
       6 h.
Repeat (i) and (ii)
Cy3, DIC, HOBt, 





DCC, HOBt, DIEA, DMF, 
3 h, 80-99%
LiAlH4, THF, 10 min
 at 0 °C, 52-90%.
 
Scheme 11 Synthesis of the vinyl sulfone library 
All the Fmoc amino aldehydes were synthesized from their corresponding Fmoc 
amino acids through a Weinreb amide formation followed by reduction using LiAlH4 to 
yield 47(a-t) in good yields. Briefly, starting from the resin-bound sulfone phosphonate 
50, a solid-phase Horner-Emmons reaction was carried out smoothly with suitably 
protected N-Fmoc-α-amino aldehyde (47) using conditions previously optimized in our 
lab generating exclusively the trans-vinyl sulfones with minimal epimerization at the 
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chiral center. Subsequently, standard solid-phase peptide synthesis protocols were used to 
attach the required peptide sequence and finally the Cy3
 
dye to yield resin 52 (a-t). The 
resulting resin-bound probes were cleaved off the resin by TFA treatment. The crude 
products were concentrated and purified by preparative HPLC and analyzed by MS. The 
purity of the probes after HPLC separation ranges from 80-95%.  
 
4.2.2 Results and conclusions from the labeling experiments 
Four cysteine proteases (i.e. chymopapain, bromelain, papain & ficin) were 
labeled with each of the 20 vinyl sulfone probes, 54 (a-t). Most proteins showed unique 
fingerprints. 











Fig. 25 SDS-page results of labeling of four proteases using the 20 vinyl sufone probes  
From the gels it is clear that for each protease, the intensity of the labeling varied with 
probes having different P
1
 amino acids. chymopapain and papain, the two homologous 
cysteine proteases known to strongly prefer basic residues, e.g. lysine and arginine, at the 
P
1 
position, accordingly showed the strongest labeling by the two corresponding probes. 
Bromelain has broad-based substrate specificity and was therefore labeled strongly by 
many of the 20 probes. 
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To demonstrate that our strategy could be used in high-throughput activity-based 
fingerprinting experiments, the same experiment was repeated in a protein microarray.  
The fingerprint patterns obtained by the two formats showed a high degree of homology 
for all the four proteins tested. The microarray based experiments were performed by a 
fellow colleague and hence the details will not be discussed herein (ref [51] for details of 
microarray based experiments). 
In conclusion, we have successfully obtained affinity binding data of the S1 
binding pocket of various cysteine proteases using a panel of cysteine protease-specific, 
activity-based probes with diverse functional groups. Having proven the high throughput 
potential this library for rapid screenings on a microarray format, similarly, one may use 
the strategy to obtain quick substrate fingerprint profiles of various classes of enzymes 
with their specific probes. Of equal importance, when a putative enzyme inhibitor is 
introduced during the microarray screening, one may generate an “inhibitor fingerprint” 
against all immobilized proteins, thus allowing potential high-throughput discovery of 
inhibitors through simultaneous assessment of both their potency and specificity.  
4.3 Experimental details of the synthesis 
4.3.1 Experimental details of the synthesis of the peptide hydroxamate library 
N-(9-Fluorenylmethoxycarbonyl)hydroxylamine, Fmoc-NHOH (39)  
 
To a mixture of NaHCO3 (1.5 g, 17.6 mmol) in water (50 ml) and ethyl acetate 
was added hydroxylamine hydrochloride (0.6 g, 8.8 mmol). The biphasic mixture was 
cooled to 0oC followed by the dropwise addition of Fmoc-Cl (2.0g, 8.0 mmol) dissolved 
in ethyl acetate for over 30 min. The mixture was stirred for 3 h at room temperature, 
after which the layers were separated and the organic layer was washed with saturated 
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KHSO4 solution (3 x 50 ml) and brine (1 x 50 ml). The organic layer was separated and 
dried over anhydrous Na2SO4. On triturating with hexane, white solid of the product was 
obtained (1.85 g, 90% yield): 1H NMR (300 MHz, CDCl3), δ 7.77 (d, J=7.6 Hz, 2H), 7.59 
(d, J=7.2 Hz, 2H), 7.40 (t, J=7.2 Hz, 2H), 7.32 (t, J=7.1 Hz, 2H), 7.18 (s, 1H), 5.64(s, 
1H), 4.51 (d, J=6.8 Hz, 2H), 4.26 (t, J=7.0 Hz, 1H). ESI-MS-[M+Na]+ = 278.1. 
 
Synthesis of hydroxylamine-functionalized resin (40)  
2-Chlorotrityl chloride resin (1.0 g, 1.2 mmol/g, Novabiochem) was swelled in 
DCM (15 mL) for 1 hour. Fmoc-NHOH (0.61 g, 2.4 mmol) was added, followed by 
DIEA (0.42 mL, 2.4 mmol). The reaction mixture was shaken at room temperature for 48 
h. The resulting resin was collected by filtration and washed with DMF and DCM, 
followed by capping with DCM/MeOH/DIEA (17:2:1) (10 mL) for 30 min. The resin 
(substitution level: 0.80 mmol/g) was collected by filtration and washed with DMF, DCM 
and MeOH. Prior to deprotection, the resin was swelled in DCM (12 mL) for 1 h. 
Piperidine (3 mL) was subsequently added and the mixture was shaken for 30 min. The 
resin was collected by filtration and washed extensively with DMF, DCM and MeOH. 
The resin 3 was dried in vacuo overnight.  
Loading of Leu at P1 position 
The resin was pre-swelled in DMF for 1 h. In a separate reaction vessel, Fmoc-
Leu-OH (4 equiv), TBTU (2-(1-H-benzotriazol-1-yl)-1, 1, 3, 3-tetramethyluronium 
tetraborofluorate) (4 equiv), and HOBt (4 equiv) were dissolved in a minimum amount of 
DMF. DIEA (8 equiv) was then added, and the reaction mixture was shaken for 10 min. 
The solution was subsequently added to the resin.  The resulting reaction mixture was 
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then agitated for 24 h after which the resin was washed DMF, DCM and MeOH and dried 
in vacuo overnight to yield resin 41.  
Loading of next amino acids 
Resin 41 (50 mg) was weighed into each well of 96-well block reactor system. 
Deprotection was carried out using 20% piperidine/DMF (30 min); the resin was then 
washed with DMF (3x), DCM (3x) and DMF (3x). Preactivated solutions of a unique 
fmoc-amino acid (P) or isokinetic mixtures of fmoc-amino acids (X) (4 equiv), HBTU (4 
equiv), HOBt (4 equiv), and DIEA (8 equiv) were added into each well, and the reaction 
mixtures were agitated for 6 h. Reagents were drained, and the resin was washed with 
DMF, DCM and DMF to yield the P2 coupled resin 42. Fmoc deprotection was carried 
out using 20% piperidine/DMF as before. The resin was washed again with DMF, DCM 
and DMF. Subsequent coupling steps were carried out using similar protocols till the 
desired peptide sequences are obtained in each well. Double couplings were done 
throughout the peptide synthesis to ensure the quality of the library. Unreacted sites were 
capped by treating the resin with acetic anhydride (10 equiv) and DIEA (20 equiv) in 
DMF for 30 min if necessary. The final wash of the resin was carried out with DMF, 
DCM and MeOH and the resin was dried in vacuum overnight. Cleavage of the peptide 
from the resin was carried out with a cleavage cocktail consisting of TFA/thioanisole/ 
anisole/EDT (90/5/3/2; 2 mL) for 2 h. The filtrate was triturated in cold ether. The 
precipitated peptides (45) were collected, washed repeatedly with cold ether, and dried in 




Dose-dependent inhibition experiments with PS library  
The gel-based, dose-dependent inhibition experiments were done with varied 
concentrations of inhibitors. Briefly, 2 μL of thermolysin solution (100 ng/μL) was 
diluted with 18 μL of Tris.HCl buffer (50 mM, pH 8). 2 μL of a desired inhibitor with 
varied concentrations 0.01, 0.05, 0.1, 0.5, 1, 5, 10 nM (dissolved in H2O, with or without 
< 10% DMSO depending on the solubility of the inhibitor), was added followed by 0.2 
μL of the photoaffinity probe (50 μM in DMSO; final concentration in the reaction: 500 
nM). The reaction was incubated at room temperature in the dark for 15-30 min, 
irradiated under UV for 20 min. The reaction was quenched by the addition of 4 μL of 6 x 
SDS loading buffer followed by boiling at 95 oC for 10 min. Samples were analyzed on a 
12% denaturing SDS-PAGE gel and fluorescence was detected with the Typhoon 
fluorescence gel scanner.  
.   
Fig. 26 IC50 plots of two representative members of the PS library 
The fluorescent bands, corresponding to the labeled thermolysin, were quantitated with 
the ImageQuant software (Amersham, USA), and the IC50 of the inhibitor was calculated 
by fitting the resulting dose-dependent data with the PRISM software. IC50 plots of two 
representative members of the PS library are given below (refer Fig. 22 b for the IC50 
value of other members). 
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4.3.2 Experimental details of the synthesis of the vinyl sulfone library 
 
4-[(Diethoxyphosphoryl) thiomethyl] benzoic acid (48) 
To a dried flask flushed with N2 was added 4-mercapto-benzoic acid (7.7 g, 50.0 
mmol), 100 ml methanol, diethyl iodomethyl phosphonate (13.9 g, 50 mmol), and DBU 
(16 ml, 105 mmol). The reaction was stirred at room temperature for 6 h. The resulting 
mixture was neutralized by a 5 M HCl solution and 400 ml ethyl acetate was added.  The 
organic layer was washed with diluted HCl solution and brine, dried over MgSO4 and 
concentrated to give an oily solid. The pure product 48 was obtained from re-
crystallization from hexane/ethyl acetate.  Yield: 77.0% (11.7 g, 38.5 mmol).  1H NMR 
(300 MHz, CDCl3) δ 7.95 (d, J = 6.8 Hz, 2H), 7.41 (d, J = 8.4 Hz, 2H), 4.19 (p, 4H), 3.29 
(d, J = 14.0 Hz, 2H), 1.32 (t, 6H). 31P NMR (121.5 MHz, CDCl3) δ 22.5; ESI mass 
spectrum: [M+H] + calc: 305.2; found 305.0.  
 
Synthesis of Rink sulfide phosphonate resin (49) 
To a 50 ml eppendorf tube was added a solution of 20% piperidine in NMP and 
1.5 g of Rink Amide AM resin (loading: 0.7 mmol/g). The mixture was shaken for 30 
min. The resin was filtered and washed with DMF, DCM and DMF. 4-
[(diethoxyphosphoryl) thiomethyl] benzoic acid (3.3 eq), HOBt (3.3 eq) and DIC (3.3 eq) 
were dissolved in minimal amount of DMF and added to the resin. DIEA (6.0 eq) was 
added and the reaction mixture was agitated overnight at room temperature. The resin 
was then washed with DMF, DCM and DMF. Subsequently, Fmoc group was cleaved by 
treating the resin with a solution of 20% piperidine in DMF for one hour. The resin was 
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filtered and washed with DMF, DCM and DMF and dried in vacuum. About 10 mg of the 
resin was cleaved by 50% TFA in DCM and analyzed by HPLC. ESI-MS for the cleaved 
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2.3 Synthesis of rink sulfone phosphonate resin (50) 
          To 1.5 g of resin 49 in 15 ml eppendorf tube was added DCM (12 ml) and m-
CPBA (3.5 eq) and the reaction mixture was agitated for 1 hour at room temperature. The 
resin was then washed with DMF, DCM and MeOH and dried in vacuum. About 10 mg 
of the resin was cleaved by 50% TFA in DCM and analyzed by HPLC. 1H NMR (300 
MHz, CDCl3) δ 7.9-8.1 (m, 4H), 4.17 (p, 4H), 3.77 (d, J=16.9 Hz, 2H), 1.31 (t, 6H), 
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2.4 Synthesis of Fmoc-AA-CHO (47) 
To a dried flask flushed with N2 was added Fmoc-AA-OH (3 mmol), N-
hydroxybenzotriazole (0.51 g, 3.3 mmol), dicyclohexylcarbodiimide (0.68 g, 3.3 mmol) 
and 6 ml DMF. After stirring for 30 min at room temperature, the solid formed was 
removed by filtration. N,O-dimethylhydroxylamine (0.35 g, 3.6 mmol),  N,N’-
diisopropylethylamine (0.46 g, 3.6 mmol) and another 4 ml DMF were added.  After 3 h, 
the mixture was concentrated.  The crude oil was dissolved in ethyl acetate and washed 
with saturated sodium bicarbonate, 0.1 M hydrochloric acid and brine.  The organic layer 
was dried (MgSO4), concentrated in vacuum to yield 46. LiAlH4 (137 mg, 3.6 mmol) was 
added to 46 (2.55 mmol) in THF (10 ml) at 0 oC.  The reaction was stirred for 10 min and 
quenched by addition of 10 ml 5% KHSO4.  After aqueous work-up, the pure product 47 
was obtained by purification with flash chromatography. Selected NMR spectra for this 
series of compounds are shown below: yield 52-90%. 
Fmoc-Asn(Trt)-H: 1H NMR (300 MHz, CDCl3) δ 9.57 (s, 1H), 7.20-7.90 (m, 23H), 










143.6, 141.2, 130.0, 128.5, 128.0, 127.7, 127.2, 127.0, 125.0, 119.9, 71.0, 67.1, 60.3, 
56.7, 47.1, 37.3. [M+H]+ calc: 581.2; found: 580.9. 
Fmoc-Asp(tBu)-H: 1H NMR (300 MHz, CDCl3) δ 9.64 (s, 1H), 7.20-7.90 (m, 8H), 4.10-
4.50 (m, 4H), 2.86 (m, 2H), 1.31 (s, 9H). 13C NMR (75.5 MHz, CDCl3)  δ 198.7, 170.1, 
156.1, 143.6, 141.2, 127.7, 127.0, 125.0, 120.0, 82.1, 67.2, 56.5, 47.0, 35.6, 27.9. 
 
Fmoc-Gln(Trt)-H: 1H NMR (300 MHz, CDCl3) δ 9.43 (s, 1H), 7.10-7.90 (m, 23H), 
4.10-4.60 (m, 4H), 2.30 (m, 2H), 1.70 (m, 2H). 13C NMR (75.5 MHz, CDCl3)  δ 198.6, 
170.8, 156.4, 144.4, 143.7, 143.6, 141.3, 128.6, 127.9, 127.6, 127.0, 124.9, 119.9, 70.6, 
66.6, 59.4, 47.2, 32.4, 24.5. [M+H]+ calc: 595.3; found: 594.7. 
 
Fmoc-Glu(tBu)-H: 1H NMR (300 MHz, CDCl3) δ 9.57 (s, 1H), 7.20-7.90 (m, 8H), 4.10-
4.60 (m, 4H), 2.33 (m, 2H), 1.89 (m, 2H), 1.45 (s, 9H). 13C NMR (75.5 MHz, CDCl3)  δ 
198.8, 172.1, 156.1, 143.6, 141.2, 127.7, 127.0, 125.0, 119.9, 81.0, 66.9, 59.6, 47.1, 30.8, 
28.0, 23.9.  ESI-MS: [M+H]+ calc: 410.2; found: 409.7. 
 
Fmoc-His(Trt)-H: 1H NMR (300 MHz, CDCl3) δ 9.68 (s, 1H), 7.10-7.90 (m, 23H), 6.63 
(s, 1H), 6.47 (d, J = 6.8 Hz, 1H), 4.10-4.60 (m, 4H), 3.10 (m, 2H). 13C NMR (75.5 MHz, 
CDCl3) δ 200.2, 156.3, 143.8, 142.2, 141.2, 138.7, 135.8, 129.6, 128.0, 127.6, 127.0, 
125.1, 119.9, 119.6, 75.3, 67.1, 59.8, 47.1, 27.6. ESI-MS: [M+H]+ calc: 604.3; found: 
603.8.  
Fmoc-Ile-H: 1H NMR (300 MHz, CDCl3) δ 9.68 (s, 1H), 7.20-7.90 (m, 8H), 4.10-4.60 
(m, 4H), 2.07 (br, 1H), 1.2-1.6 (m, 2H), 0.9-1.1 (m, 6H). 13C NMR (75.5 MHz, CDCl3) δ 
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199.8, 156.2, 143.7, 141.2, 127.6, 127.0, 124.9, 119.9, 66.9, 64.5, 47.1, 36.3, 25.2, 15.5, 
11.8.  ESI-MS: [M+H]+ calc: 338.2; found: 337.7. 
 
Fmoc-Leu-H: 1H NMR (300 MHz, CDCl3) δ 9.58 (s, 1H), 7.20-7.90 (m, 8H), 4.10-4.60 
(m, 4H), 1.71 (br, 2H), 1.30 (br, 1H), 0.97 (d, J = 4.4 Hz, 6H). 13C NMR (75.5 MHz, 
CDCl3) δ 199.6, 156.1, 143.7, 141.2, 127.6, 127.0, 124.9, 119.9, 66.8, 58.7, 47.1, 38.0, 
24.5, 23.0, 21.8. ESI-MS: [M+H]+ calc: 337.5; found: 337.7.  
 
Fmoc-Lys(Boc)-H: 1H NMR (300 MHz, CDCl3) δ 9.57 (s, 1H) 7.20-7.90 (m, 8H), 4.10-
4.60 (m, 4H), 3.11 (br, 2H), 1.2-1.7 (m, 15H). 13C NMR (75.5 MHz, CDCl3) δ 199.2, 
156.1, 143.6, 141.2, 127.6, 127.0, 124.9, 119.9, 79.2, 66.9, 60.0, 47.1, 39.7, 33.8, 29.7, 
28.4, 22.0. ESI-MS: [M+H]+ calc: 453.2; found: 452.7.  
 
Fmoc-Phe-H: 1H NMR (300 MHz, CDCl3) δ 9.64 (s, 1H), 7.10-7.90 (m, 12H), 4.10-4.60 
(m, 4H), 3.15 (d, J = 6.4 Hz, 2H). 13C NMR (75.5 MHz, CDCl3) δ 198.6, 155.8, 143.6, 
141.3, 135.4, 129.2, 128.7, 127.7, 127.1, 127.0, 124.9, 119.9, 66.9, 61.0, 47.1, 35.3. ESI-
MS: [M+H]+ calc: 372.2; found: 371.7. 
 
Fmoc-Ser(tBu)-H: 1H NMR (300 MHz, CDCl3) δ 9.62 (s, 1H), 7.20-7.90 (m, 8H), 4.10-
4.50 (m, 4H), 3.96 (dd, J = 3.0, 9.1 Hz, 1H), 3.64 (dd, J = 4.2 & 9.3 Hz, 1H), 1.17 (s, 
9H). 13C NMR (75.5 MHz, CDCl3)  δ 199.0, 156.1, 143.7, 141.2, 127.6, 127.0, 125.0, 
119.9, 73.7, 67.0, 60.4, 59.9, 47.1, 27.1. ESI-MS: [M+H]+ calc: 368.2; found: 367.7. 
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Fmoc-Thr(tBu)-H: 1H NMR (300 MHz, CDCl3) δ 9.73 (s, 1H), 7.20-7.90 (m, 8H), 4.10-
4.60 (m, 5H), 1.24 (s, 9H), 1.14 (d, J = 6.0 Hz, 3H). 13C NMR (75.5 MHz, CDCl3)  δ 
200.6, 156.3, 143.7, 141.2, 127.6, 127.0, 125.0, 119.9, 74.6, 67.0, 66.1, 65.4, 47.1, 28.3, 
19.4.  
 
Fmoc-Trp(Boc)-H: 1H NMR (300 MHz, CDCl3) δ 9.66 (s, 1H), 7.20-7.90 (m, 13H), 
4.10-4.60 (m, 4H), 3.30 (m, 3H), 1.62 (s, 9H). 13C NMR (75.5 MHz, CDCl3) δ 198.8, 
155.9, 149.4, 143.6, 141.2, 135.4, 130.0, 127.7, 127.0, 124.9, 124.7, 124.2, 122.8, 120.0, 
118.8, 115.3, 114.4, 83.8, 67.1, 59.7, 47.0, 28.1, 25.2. [M+H]+ calc: 511.2; found: 510.9. 
 
Fmoc-Tyr(tBu)-H: 1H NMR (300 MHz, CDCl3) δ 9.61 (s, 1H) 6.90-7.90 (m, 12H), 4.10-
4.50 (m, 4H), 3.10 (d, J = 6.4 Hz, 2H), 1.36 (s, 9H). 13C NMR (75.5 MHz, CDCl3) δ 
198.8, 155.8, 154.4, 143.6, 141.3, 130.1, 129.7, 127.7, 127.0, 124.9, 124.2, 119.9, 78.4, 
66.8, 61.1, 47.1, 34.6, 28.8. ESI-MS: [M+H]+ calc: 444.2; found: 443.7. 
 
Fmoc-Val-H: 1H NMR (300 MHz, CDCl3) δ 9.66 (s, 1H), 7.20-7.90 (m, 8H), 4.10-4.60 
(m, 4H), 2.32 (br, 1H), 1.04 (d, J = 6.8 Hz, 2H), 0.97 (d, J = 6.8 Hz, 2H). 13C NMR (75.5 
MHz, CDCl3) δ 199.6, 156.3, 143.7, 141.2, 127.6, 127.0, 125.0, 119.9, 66.9, 65.0, 47.1, 
29.0, 18.9, 17.5 ESI-MS: [M+H]+ calc: 324.2; found: 323.8. 
 
Representative Synthesis of 51 (a-t) 
 To 200 mg of phosphonate resin 50 was added 5 ml of anhydrous THF. After swelling 
for 1 h, 2 ml of THF was removed by suction using a syringe. To the remaining solution 
 104
was added 1 M LHMDS solution in THF (5 equiv.) and the reaction was stirred gently 
for 30 min. The reaction was stopped by removing the solution by suction. About 15 ml 
of anhydrous THF was added and the mixture further stirred for 5 min. The solution was 
again removed by suction as described before. This process was repeated a few times. 
Fmoc-protected amino aldehyde (3 eq, dissolved in 1 ml of THF) was added to the resin, 
and the resulting solution was topped up to ~ 5 ml with THF. The reaction was stirred for 
another 2 h, and the resin was filtered and washed with DMF, DCM and DMF.and dried 
in vacuum.  
 
Representative Synthesis of Probes 54 (a-t) 
 To 200 mg of resin 51(a-t) was added 3 ml of DBU/HOBT/DMF (2:1:97) solution and 
the reaction was allowed to proceed for 10 min to cleave off the Fmoc group. The 
resulting resin was filtered and washed extensively with DMF, DCM and DMF. A 
solution containing Fmoc-Leu-COOH (4 eq), HOBT (4 eq), DIC (4 eq) and DIEA (8 eq) 
in minimal amount of DMF was then added and the reaction was allowed to proceed for 6 
hours. The Fmoc-deprotection and coupling steps were repeated to attach the second leu 
residue and the Cy3 dye. The resin was washed with DMF, DCM and MeOH and dried in 
vacuum, 53 (a-t). The peptides were cleaved off the resin with 1.5 ml of TFA/TIS/H2O 
(95/2.5/2.5) mixture for 2 h. The filtrate was evaporated in vacuum to remove TFA and 
subjected to preparative HPLC purification to yield the final probes 54 (a-t). All the 
probes were characterized by ESI-MS and summarized in Table 4. The stock solutions of 
the 20 probes (200 µM in DMSO) were prepared and stored at -20 0C until use.  
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No  Compound  (M-1)
- 
calc. Found 
54a  Cy3-LLA-VS  905.5  905.5  
54b  Cy3-LLD-VS  949.5  949.5  
54c  Cy3-LLE-VS  963.5  963.5  
54d  Cy3-LLF-VS  981.5  981.5  
54e  Cy3-LL-dF-VS  981.5  981.5  
54f  Cy3-LLG-VS  891.5  891.5  
54g  Cy3-LLH-VS  971.5  971.5  
54h  Cy3-LLI-VS  947.5  947.5  
54i  Cy3-LLK-VS  962.5  962.6  
54j  Cy3-LLL-VS  947.5  947.5  
54k  Cy3-LLN-VS  948.5  948.4  
54l  Cy3-LL-Orn-VS 948.5  948.5  
54m  Cy3-LLP-VS  931.5  931.5  
54n  Cy3-LLQ-VS  962.5  962.5  
54o  Cy3-LLR-VS  990.6  990.4  
54p  Cy3-LLS-VS  921.5  921.4  
54q  Cy3-LLT-VS  935.5  935.5  
54r  Cy3-LLV-VS  933.5  933.6  
54s  Cy3-LLW-VS  1020.5  1020.5 
54t  Cy3-LLY-VS  997.5  997.6  
         
Table 4 ESI-MS data for vinyl sulfone library  
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Gel-baesd labeling experiments 
The probes were prepared as a 5 mM (0.5 mg/ml)  stock solution in DMF. 2.0 µL 
of the protein solution was diluted with 18 µL of reaction Buffer (50 mM CH
3
COONa at 
pH 5, 2 mM DTT, 1 mM EDTA). 0.2 µL of the probe (200 µM) was then added and the 
reaction mix was incubated at room temperature in the dark for 15 min. The reaction was 
quenched by boiling the sample at 950C for 5 min with 4 µL of 6x SDS-PAGE loading 
dye. The sample was then resolved on a 12% SDS-PAGE gel and visualized by 
fluorescence scanning using the Typhoon 9200 scanner (Amersham, USA). 
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Chapter 5 Synthesis of molecular probes for potential bioimaging 
experiments 
5.1 Introduction 
Site-specific labeling methods represent the major bottleneck for the use of 
molecular probes in the cellular environment. In Chapter 1, we have discussed a number of 
site specific methods used by various groups for live cell imaging purposes [76-86]. 
Currently only a few techniques are available for non-covalent fluorescence labeling with 
well-defined localization of the attached dye [84-86]. Here, we present an attempt focusing 
on developing general strategies to carry out live cell imaging of proteins using a well-
known non -covalent interaction, the NTA-histidine interaction co-ordinated through a Ni2+ 
ion.  
The importance of immobilized cations in the chromatographic purification of 
proteins was known as early as in 1975. The chelating ligands iminodiacetic acid (IDA) 
and N,N,N’-tris(carboxymethyl)ethylenediamine (TED) have since been used successfully 
for the purification of many peptides and proteins. In 1987, nitrilotriacetic acid (NTA) was 
introduced as a promising quadridentate chelating adsorbent for protein purification 
purposes [168]. NTA occupies four positions in the metal coordination sphere of Ni2 +. The 
remaining two binding sites are accessible to electron donor groups. In the case of proteins, 
these electron donor groups are the side chains of amino acids such as histidine, cysteine, 
and, to some extent, glutamate, aspartate, arginine, or lysine. The chelate formation has 
been made generally applicable for protein purification by introducing a short stretch of 
five to six histidines at defined positions of the protein.  
 108
Oligohistidine tags have been used for in vitro detection of proteins previously – the 
work done by Kapanidis et al. is a typical example [169]. They developed a novel method 
for the fluorescent labeling of proteins. They used NTA derivatives of cyanine fluorophores 
and showed that these fluorescent molecules can function as fluorescence resonance energy 
transfer (FRET) acceptors for fluorescein-labeled histidine-tagged DNA-protein 
complexes. In the present work, we sought to extend the strategy to the labeling of 
hexahistidine tagged proteins expressed inside live bacterial cells using modified cell-
permeable probes. We expected the selective labeling of target proteins to occur efficiently. 
But unfortunately, our preliminary observations exemplified potential problems to 
materialize the labeling using the strategy we envisioned. The present chapter briefly 
explains the synthesis of the probes, the biological experiments we have done and also 
discussed the possible reasons for the failure of our strategy. 
5.2 Design of the NTA probes 
The probe has three units, NTA, linker and a chromophore. The role of the NTA 
ligand is to bind the protein of interest with good affinity. The lysine linker helps to avoid 
the proximity of the chromophore group from the target protein and the chromophore helps 
in visualizing the labeling. The two probes synthesized are the NTA derivatives of 
fluorescein di-acetate and tetramethylrhodamine (FL and TMR) representing cell-
permeable analogs of fluorophores in two different colors (green and orange red, 
respectively) for potential multi-color labeling of proteins. Acetate groups on the FL probe 
are spontaneously hydrolyzed inside the cell by endogenous esterases, releasing the highly 
fluorescent free dye. The expected interaction between a His-tagged protein and our NTA 
probe is as shown in Fig. 27.  Each Ni2+ chelates with one nitrilotriacetic acid and 











































Fig. 27 The NTA probes and the mechanism of labeling of histidine tagged proteins by NTA-TMR 
probe 
5.3 Chemical synthesis of the probes 
Our first attempt was to synthesize NTA starting with commercially available N-
benzyloxycarbonyl-L-lysine(Boc) and bromoacetic acid using published protocols [168]. 
The N-benzyloxycarbonyl-L-lysine(Boc) after TFA-mediated deprotection afforded N-
benzyloxycarbonyl-lysine-NH2. This compound is then reacted with bromoacetic acid 
under ice cold conditions in basic aqueous solution and the resulting product was 
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hydrogenated by Pd/C to yield Lys-NTA. Although we got Lys-NTA in good yields using 
this strategy, further couplings of the NTA to the fluorescein derivatives were hampered by 
the inherent solubility problems associated with the NTA moitey. Due to the presence of 
three carboxyl and one free amine group, the compound is very polar and insoluble in most 
solvents even at lower concentrations. This made further couplings difficult as the proper 
choice of solvents and coupling conditions necessitated consideration of other issues like 
instability/sensitivity of the diacetate groups of fluorescein to mild basic conditions, 
possibility of protonation of free NTA amine group under acidic conditions etc. Therefore 
we chose to follow another synthetic route. Commercially available Nε-benzyloxycarbonyl-
L-lysine tert-butyl ester was reacted to bromoacetic acid ethyl ester at 500C in presence of 
triethyl amine for 4 days to yield compound 55. The catalytic deprotection of N-benzyloxy 
group yielded the tert-butyl protected Lys-NTA (56) in good yields. Strategically, the 


























Scheme 12 NTA synthesis 
TMR was prepared from 3-dimethylaminophenol and trimellitic anhydride in the 
presence of methanesulfonic acid, following published protocols [130]. The carboxylic 
group of TMR was coupled to the Lys-NTA-triester to yield TMR-NTA-triester under 
EDC/HOBt coupling conditions. The TMR-NTA-triester is then deprotected under TFA 
conditions to yield the final product TMR-NTA, 58. 
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FL was prepared similarly from resorcinol 11 and trimellitic anhydride in the 
presence of methanesulfonic acid. Following acetylation of FL, the resulting product, FL-
diacetate was reacted with the Lys-NTA-triester under EDC/HOBt coupling conditions to 
yield FL-NTA-triester. The compound was then deprotected under TFA conditions to yield 














































(i) 56, EDC, DMF
RT, 12 hrs
(ii) TFA : DCM (1:1)
RT, 30 min, 8%
26% for two steps





Scheme 13 Synthesis of NTA-FL and NTA-TMR 
5.4 Results and conclusions of the labeling experiments  
The Ni2+ conjugated NTA probes (Ni2+: NTA = 5:1) were added to the cell culture 
and the labeling of the probes inside the cells was monitored by fluorescence microscopy. 
The labeling strategy is briefly explained as shown in Scheme 14. 
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               pDEST-17-GST, BL21(AI), pTWIN-ER2566-GST
Induction at OD600 (0.4-0.5)
Expression at 37oC for 3 hrs (0.2 % arabinose)
Addition of the conjugated  probe and 3 hr shaking
Washing with PBS (4 to 5 times)
Transfer to Slides
confocal microscope  
Scheme 14 The strategy of labeling target proteins with NTA probes 
The labeling of the probes inside the cells was monitored by fluorescence 
microscopy. Mild washing conditions showed more fluorescence within the cells when 
compared to that of the surrounding buffer, but with considerably significant amount of 
background labeling from the excessive probes used for labeling reactions. Normally 
background labeling is tolerable to some extent in bioimaging experiments, provided it can 
be reduced by extensive washings of the labeled cells. But in our case upon extensive 
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washing, another scenario was observed whereby the release of the probes from the cells 
resulting in the appearance of very strong fluorescence in the surrounding solution. Taken 
together, these observations lead to two different possibilities: (1) the labeling actually 
occurs, but due to the reversible nature of the NTA-Ni2+-His non-covalent interaction, the 
probe get released from His-tagged proteins and comes out of the cell - this could happen 
especially during the washing/standing processes performed after the labeling or (2) the 
labeling does not occur at all, probably due to the relatively low affinity of the coordinate 
interaction of NTA-Ni2+ with a (His)6 tag. 
Note: While our preliminary experiments were going on, Vogel et al. reported a 
generic method for the site-selective and reversible labeling of membrane proteins 
containing a polyhistidine sequence in live cells with NTA containing probes [83]. They 
too were unsuccessful in visualizing the labeling of (His) 6 tagged non-fluorescent proteins 
with their NTA probes. FRET between a fluorescent-tagged receptor and the NTA probe 
was used as an indicator of labeling. Anyway it should also be noted that a significant 
amount of background labeling was observed in their labeling experiments. 
5.5 Experimental details of the synthesis of NTA probes 
Z-Lys-NTA (OtBu), 55 
A solution of Nε-benzyloxycarbonyl-L-lysine tert-butyl ester (250 mg, 0.67 mmol), 
triethylamine (0.57 ml, 3.4 mmol), and 0.4 ml (2.7 mmol) of bromoacetic acid tert-butyl 
ester was stirred in 10 mL of DMF for 4 days at 50 °C.  The solvent and the excess of 
bromoacetic acid tert-butyl ester were removed in a vacuum, and the remaining oil was 
extracted six times with hexane. The combined organic phases were collected and the 
solvent was removed in a vacuum. 1H NMR (300 MHz, CDCl3); δ 1.24 (s, 18H) 1.45 (s, 
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9H); 1.49 (m, 4H); 2.02 (m, 2H); 3.18 (m, 2H); 2.96 (t, J=6.2 Hz, 1H), 3.46 (m, 4H); 4.12 
(s, 2H); 4.90 (t, 1H); 7.33 (m, 5H). Yield: 153 mg, 40 %. (M + 1)+ 565 m/z 
Lys-NTA (OtBu), 56 
55 (153 mg, 0.27 mmol) was dissolved in 10 mL of AcOH/MeOH (1:10). After 5 
mg of Pd/C (5% Pd) was added, compound 10 was hydrogenated at room temperature and 
normal pressure for 4 h. The catalyst was filtered off, and the reaction mixture was 
extracted twice with 1 N NaOH. The combined organic phases were dried over anhydrous 
sodium sulfate, and the organic solvent was removed in a vacuum. 1H NMR (300MHz, 
CDCl3); δ 1.24 (s, 18H) 1.27 (s, 9H) 1.41 (m, 4H) 1.52 (m, 2H); 2.09 (t, 2H); 3.11 (t, J=6.5 
Hz, 1H); 3.37 (m, 4H). Yield: 105 mg, 90%. m/z 431.0 (M + 1)+.  
5-Carboxy-tetramethylrhodamine, 57 (TMR):  
Trimellitic anhydride (1.00 g, 5.2 mmol) and 3-dimethylaminophenol, 14 (0.72 g, 
10.5 mmol) were refluxed in toluene (50 ml) for 12 hours. Upon cooling to RT, the 
resulting precipitate was collected by filtration, and further purified by flash 
chromatography (silica gel, dichloromethane/methanol/acetic acid = 8:1.9:0.1) to afford 
pure 15 as a dark purple solid (0.811 g, 36%). 1H NMR (300 MHz, CDCl3) δ 8.52 (s, 1H), 
8.12 (d, J=8.61 Hz, 1H), 7.59 (d, J=7.62 Hz, 1H), 6.82 (m, 2H), 6.51 (d, J=5.61 Hz, 2H). 
6.09 (s, 2H), 3.28 (s, 12H). MS (ESI): m/z 431.2 (M+1)+ . 
TMR-NTA , 58  
To a solution of Lys-NTA (OtBu) (50 mg, 0.12 mmol)  in DMF was added TMR 
(75 mg, 0.18 mmol) EDC (34 mg, 0.18 mmol) and the reaction was allowed to proceed 
overnight. The resulting mixture was dried in vacuo to remove DMF. The crude residue 
dissolved in EtOAC (15 ml) and washed with water (2x10ml) and brine (1x10ml). The 
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organic layer was concentrated in vacuum to give a purple residue which was then treated 
with 5 ml of TFA/DCM (1:1). The reaction was allowed to proceed at room temperature 
for 30 min. The resulting mixture was concentrated in vacuum, purified by RP-HPLC 




To a solution of Lys-NTA (OtBu) (50 mg, 0.12 mmol) in DMF was added FL-
diacetate (82 mg, 0.18 mmol) EDC (34 mg, 0.18 mmol) and the reaction was allowed to 
proceed overnight. The resulting mixture was dried in vacuo to remove DMF. The crude 
residue dissolved in EtOAC (15 ml) and washed with water (2 x 10ml) and brine (1 x 
10ml). The organic layer was concentrated in vacuum to give a yellowish white residue 
which was then treated with 5 ml of TFA/DCM (1:1). The reaction was allowed to proceed 
at room temperature for 30 min. The resulting mixture was concentrated in vacuum, 
purified by RP-HPLC. Yield: 26 mg (33 % over two steps). ESI-MS m/z 705.0 [(M+1]+ 
Represenative procedure for labeling by Ni2+NTA conjugates  
NiCl2.6H2O (350 nM in 3 μl 0.01 N HCl) was added to NTA-probe (70 nM in 2ml 
H2O) and the solution was brought to pH 7.2 by the addition of 600 μl of 1M NaOAC and 
200 μl of NaCl solution (200 mM) and the solution was shaken overnight in dark. Bacterial 
constructs transformed into E. coli expression strain (E2566) expressing hexahistidine 
tagged GST (glutathione-S-transferase). The cells were grown in 100 mg/L ampicillin 
containing LB media at 37°C in a 250 rpm air shaker. At OD600 ~ 0.5, protein expression 
was induced with 0.2% arabinose and the cells were grown for 3h at 37°C to optimize 
protein expression. For labeling, the Ni2+ conjugated NTA probe (Ni2+: NTA = 5:1) was 
added directly to the LB media ( final concentration of the probe 25 μM) and the cells were 
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incubated for various time intervals 3 h, 6 h, 12 h etc. Cells were harvested by 
centrifugation at 4000 rpm for 10 min and resuspended in PBS buffer (pH 7.4) containing 
10% glycerol and left standing for 10 min. This procedure was repeated four times for the 
complete removal of any free probe. Subsequently, the cells were used for fluorescence 
experiments. The labeling experiment was repeated under identical conditions with control 
proteins which either do not express protein at all, or have only GST without histidine tag. 
For fluorescence microscope experiments, cells were mounted on clean glass slides coated 
with 1.5% agarose. Fluorescence images were recorded with a AxioSkop 40 fluorescent 
microscope (Carl Zeiss, Germany) equipped with a cooled CCD camera (AxioCam, Zeiss) 
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Chapter 7 Appendices:  Capase-Fluorescein probe (16) – 1H NMR 
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AVLQ-ACC-Lys(N3) – ESI-MS 
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NTA-TMR (57) 
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NTA-FL (59) 
 
